CYBER CARE INC, 10KSB, 2000-04-03

CYBER CARE INC
10KSB, 2000-04-03
MEDICAL LABORATORIES

Previous: CMC SECURITIES CORP III, 8-K, 2000-04-03

Next: REVLON INC /DE/, DEF 14A, 2000-04-03

U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-KSB
- --------------------------------------------------------------------------------

[X] ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF
1934

For the fiscal year ended December 31, 1999

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934

CYBER-CARE, INC.
(Exact name of registrant as specified in its charter)

Commission file number: 0-20356

FLORIDA 65-0158479
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) identification No.)

1903 SOUTH CONGRESS AVE., SUITE 400
BOYNTON BEACH, FLORIDA 33426
(Address of Principal Executive Office)

(561) 737-2227
(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Exchange Act: None

Securities registered pursuant to Section 12(g) of the Exchange Act: Common
Stock

Check whether the issuer: (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.

Yes [X] No [ ]

Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B is not contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. [ ]

Issuer's total revenues for the 12 months ended December 31, 1999 were
$39,155,664.

The aggregate market value of the voting stock held by non-affiliates of the
registrant, based on the last sales price on the Nasdaq SmallCap Market on March
24, 2000 was $703,692,000. As of March 24, 2000 registrant had 57,356,246 shares
of Common Stock outstanding.
<PAGE>
TABLE OF CONTENTS

ITEMS PAGE
PART I

ITEM 1. DESCRIPTION OF BUSINESS....................................3

ITEM 2. DESCRIPTION OF PROPERTIES.................................14

ITEM 3. LEGAL PROCEEDINGS.........................................15

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.......15

PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED SHAREHOLDER MATTERS..16

ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS......................17

ITEM 7. FINANCIAL STATEMENTS......................................21

ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE.......................21

PART III

ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL
PERSONS; COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE
ACT ......................................................22

ITEM 10. EXECUTIVE COMPENSATION....................................24

ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT............................................28

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS............30

ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K..........................30

2
<PAGE>
PART I

ITEM 1. DESCRIPTION OF BUSINESS

GENERAL

We own and are developing an Internet-based solution and interactive system (The
Electronic HouseCall System ("EHC System")) that provides products and services
to support remote delivery of care, patient monitoring and education to the
United States and worldwide healthcare markets. We also have been in the
business of developing, owning and operating integrated medical delivery
services through our diversified medical technologies, physical, occupational
and speech therapy, sleep apnea, diagnostic and other healthcare services,
institutional and e-commerce pharmacy services and international air ambulance
transport services.

We were incorporated in September 1989 in the State of Florida. In August 1999,
we changed our name to Cyber-Care, Inc. ("CYBR or CyberCare") to more accurately
reflect our focus into the medical internet-based technology industry. Our
principal executive offices are located at 1903 S. Congress Ave., Suite 400,
Boynton Beach, Florida 33426 ,our telephone number is (561) 737-2227, and our
website address is www.cyber-care.net.

PROPOSED REVIEW AND CHANGES IN BUSINESS STRATEGY

Our business strategy currently being reviewed and developed by the board
of directors, is to focus our primary attention on our EHC System and technology
products. We will continue to operate our other businesses and gradually spin
them off to our shareholders or sell the segments that do not fit into our plans
to strategic partners or potential buyers as the opportunities arise, to
maximize shareholder value and increase technology revenue.

In August 1999, we acquired CyberCare, Inc. (CyberCare Technologies) which
is developing an Internet-based solution and interactive system providing
products and network services (EHC System) to support remote delivery of care,
patient monitoring and education to the United States and international
healthcare markets. We subsequently acquired certain assets of Help Innovations,
Inc. which provided additional technology and an application and a library of
computerized disease management protocols that will assist us in delivering
services through the Internet.

These acquisitions changed our overall business strategy. Previously, we
focused our growth objectives on identifying companies that could be acquired at
favorable prices which could be rolled up quickly with significant market
penetration in the ancillary healthcare field. Accordingly, we identified the
international air ambulance business and made two acquisitions resulting in our
becoming the largest air ambulance business in the United States.

We also identified the physical therapy and rehabilitation field as a
target and acquired three companies resulting in our becoming the largest
physical therapy and rehab company in Florida today.

These business segments also provided us with the opportunity to identify
customers for our EHC System and generate orders helping us become an
international healthcare Internet based technology company focusing on our EHC
System.

We are currently reviewing and developing our long-term strategy with our
board of directors to focus our energies on expanding our business as follows:

o Primary focus will be the development of the EHC System products and Internet
technology services on a worldwide basis.

3
<PAGE>
o Continue to operate the air ambulance business to increase revenues,
profitability and create synergies for our technology business. We will look
for an appropriate buyer, or spin off the company to existing shareholders
when appropriate, retaining a relationship with the new company, to add value
and revenue to our Internet based technology business.

o Continue to operate our physical therapy and rehabilitation operations
through internal growth and acquisitions, while looking for an appropriate
buyer or partner, or spin off the business to existing shareholders. The
future of this business segment will be based on all factors, including fair
market value of the business, ability to increase technology revenue by
providing these services through our EHC System and optimizing shareholder
value.

o Continue to operate our pharmacy business, find an appropriate strategic
partner for our institutional pharmacy business and, if possible, enter into
a strategic alliance to provide e-pharmacy business through our Electronic
HouseCall System. We could eventually sell this business to the strategic
partner.

We believe that by concentrating on our Internet based technology
operations and developing our businesses to maximize technology revenue and
profitability, our management can focus its energies and resources on our
technology business, retain and grow important healthcare relationships thereby
increasing technology revenue and maximizing shareholder value.

BUSINESS OPERATIONS

TECHNOLOGY ASSISTED DISEASE MANAGEMENT SEGMENT.

In August 1999, we acquired Cybercare, Inc. (CyberCare Technologies), a
privately-held Georgia corporation, which was developing an Internet based
solution and interactive system which provides products and services to support
remote delivery of healthcare, patient monitoring and education to patients in
the United States and worldwide. CyberCare Technologies' offices are located in
Atlanta, Georgia.

During 1999, our Technology Assisted Disease Management segment accounted
for 4.1 % of our consolidated revenues from operations.

CyberCare Technologies was formed for the purpose of developing and
marketing disease management solutions through telemedicine technologies and to
acquire the rights to the technologies developed by the Georgia Institute of
Technology and the Medical College of Georgia for monitoring chronically ill
patients in their homes or other remote locations.

We continue to develop, manufacture, operate and market, subject to FDA
approval in the United States, Internet based technology and interactive systems
for use in disease management. This technology will support remote delivery of
care, patient monitoring and education to the U.S. and international healthcare
markets. We intend to target our initial product system specifically for the
high-cost, chronically ill patient population and specific markets in Southeast
Asia. Management believes that preventive services for this patient population
is an untapped multi-billion dollar market in the United States alone. We
believe that our expertise in providing services to payors and managed care
companies combined with our Internet connectivity technology will allow us to
link patients directly to healthcare providers.

We will continue to develop, refine, produce and market our key
technologies for monitoring chronically ill patients in the home and elsewhere.
CyberCare Technologies is expected to achieve operational efficiencies through
the synergy with our existing relationships with managed care companies and
other healthcare providers.

4
<PAGE>
OUR INTERNET SOLUTIONS. Our initial e-business product is the Electronic
HouseCall System, which is a care management system with two major
components: (the patient modules, 5 models, and the caregiver module) and
network services.

The patient module consists of a multimedia personal computer with video
conferencing capability with a very simple touch-screen user interface. The
patient modules also include interface drivers and medical devices which are
used by the patient to automatically collect vital diagnostic information,
including weight, temperature, blood pressure, ECG, heart and lung sounds
(electronic stethoscope), blood oxygen level, pulse rate, blood glucose levels,
etc. Vital sign information collected by the patient module is automatically
recorded in an electronic patient record maintained by the system within the
network. The patient module has been packaged into a small, portable unit called
the personal care management system which a nurse can carry into a patient's
home for connection to standard telephone lines or other network interfaces.

The caregiver module is also a personal computer-based application with
specialized software to permit a doctor or nurse to monitor a patient's vital
signs information and communicate directly with those patients. Both modules
function together so that measurement devices may be controlled from either end
and results are automatically collected, charted, and maintained for permanent
records.

The network services link these patients and caregivers together into a
common environment, where resources can be made available 24 hours a day, seven
days a week, whenever the patient needs assistance utilizing our patented
intelligent routing capability.

MATERIAL AGREEMENTS. The technologies we use in our e-commerce business
have been licensed to CyberCare Technologies under an exclusive license
agreement with Georgia Tech Research Corporation and the Medical College of
Georgia. This license agreement gives us the exclusive worldwide rights to the
intellectual property developed by the universities in this area, and also gives
us rights to future technology developed by the universities. This license
agreement further provides for royalty payments to the universities based on net
sales, as defined. In addition, this license agreement provides for ongoing
research and development support by the universities for our business
activities.

The exclusive license covers the packet-based telemedicine system and for
communicating video, voice and medical data between a central monitoring station
and a patient monitoring station which is remotely located. The information is
encapsulated in packets and can be sent over multiple types of network
architectures, including CATV network, PSTN, ISDN, DSL, the Internet, LAN, WAN,
over a wireless communications network or over an ATM network. By sending the
information in packets, the video, voice and measurement data can be integrated
and sent over a single network.

We also have a joint marketing agreement with Nortel Networks, Inc.
("Nortel"), which provides for Nortel's sales personnel to cultivate sales leads
to Cybercare Technologies and to work jointly to sell CyberCare Technologies'
products to Nortel's customers. We have a distribution agreement in place with
Healthlink Group, LLC ("Healthlink"), which provides that Healthlink will market
our EHC System products and services for use in assisted living facilities in
designated markets and requires that Healthlink maintain certain performance
objectives.

We have signed a joint venture agreement, subject to certain conditions,
with SIIC Medical Science and Technology (Group) Limited ("SIIC Medical") (a
public company on the Hong Kong Growth Enterprise Board (GEM): 363) to market
and sell approximately 64,000 EHC units over four years with a minimum of 30,000
EHC units sold to retain the exclusive license for the greater China area, not
including Taiwan. The joint venture plans on initially selling the units in Hong
Kong and mainland China.

We have also received orders from Health System One, Inc., Cambridge
Medical Centers, Inc., Americhoice Health Services, Inc., Evangelical Lutheran
Good Samaritan Society of Sioux Falls, Metcare, and received other orders and
commitments for over 36,000 units to be sold over the next three years.

5
<PAGE>
HELP INNOVATIONS. Effective November 15, 1999 we acquired patents,
products and key personnel from Help Innovations, Inc. for $2,709,354 in common
stock priced at $2.03 per share. Through Help Innovations, we own a library of
computerized disease management protocols that will assist us in delivering
services through the Internet. The electronic patient record application is
accessible over our network for efficient tracking of patient outcomes. Help
Innovation's patented technology will significantly complement our product line.

PHYSICAL THERAPY AND REHABILITATION SERVICES SEGMENT.

During 1999, our rehabilitation services segment accounted for 24.6% of
consolidated revenues from operations.

YOUR GOOD HEALTH NETWORK. In October 1998, we acquired Your Good Health
Network, Inc. (YGHN), which provides physical, occupational, speech therapy and
pain rehabilitation services. Through YGHN we intend to develop physical therapy
and rehab clinics within specific geographic locations which we believe will
create synergies and operating efficiencies and satisfy the cost containment
requirements of significant payor sources.

We currently own and operate forty-nine rehabilitation and physical
therapy clinics. YGHN currently employs approximately 100 people, including nine
employees in our corporate office who provide management and administrative
services. On average, each physical therapy clinic typically has three staff,
including a fully licensed therapist, a licensed therapy assistant and an
administrative secretary/rehabilitation aide.

Our physical therapy and rehabilitation services include: specialty
programs like pain management, coupled with traditional services such as primary
care, orthopedic and neurological physician services and comprehensive
rehabilitation. These services allow us to be a unique healthcare provider. Our
strategy is to provide services that are less reliant upon governmental
reimbursement and to diversify our payor sources to a fee-for-service basis. We
are focused on being minimally reliant upon managed care payors.

CAROLINA REHAB. Effective August 1, 1999, we acquired all the issued and
outstanding capital stock of Carolina Rehab, Inc. and Outreach Programs, Inc.
("Carolina") in exchange for shares of CYBR's common stock, to be paid in three
installments in accordance with "earn-out" provisions as follows:

The first installment will be paid to the former shareholders of Carolina
in shares of our common stock in an amount equal to the pre-tax net profits of
Carolina calculated in accordance with generally accepted accounting principles
("GAAP"), times three. Fair market value of each share, for purposes of the
first installment payment, shall be $1.25 per share. The second and third
installments will be paid in shares of our common stock equal to the incremental
increase in profit, times three. Fair market value of each share, for purposes
of the second and third installments, shall be the ninety-day trailing average
of the stock prices as of the last trading day of the second and third periods.

Carolina is a Medicare certified Comprehensive Outpatient Rehabilitation
Facility ("CORF") providing physical, occupational and speech therapy services
in 50 clinics throughout Florida.

SOUTHEAST MEDICAL CENTERS. Effective August 1, 1999, we acquired all the
issued and outstanding capital stock of Southeast Medical Centers, Inc. in
exchange for shares of our common stock, to be paid in three installments in
accordance with "earn-out" provisions as follows:

Three installments will be paid in shares of our common stock in an amount
equal to Southeast's pre-tax net profits calculated in accordance with GAAP, for
each of the three years ending July 31 following the effective date of the
acquisition. Fair market value of each share, for purposes of the first
installment, shall be the ten-day trailing average of the stock price as of the
effective date of the acquisition but not to exceed $400,000. Fair market value
of each share, for purposes of the balance of the first installment in excess of
$400,000, if any, and for the second and third installments, will be the ten day
trailing average of the stock price as of the delivery date.

6
<PAGE>
Southeast Medical provides physical therapy and other health care services
with five locations in South Florida.

INTERNATIONAL AIR AMBULANCE TRANSPORT SEGMENT

During 1999, our international air transport segment accounted for 55.6%
of consolidated revenues from operations.

We are capitalizing on what management believes is the growing and
segmented air ambulance industry. Through our air ambulance segment, we offer
national and international fixed-wing air ambulance transport services to ill,
injured or otherwise incapacitated persons requiring relocation and possible
emergency medical care during flight. Circumstances requiring our transport
services include the relocation of patients requiring specialized medical
procedures such as organ transplants, cancer treatment, specialized cardiac
surgery, burn care, stroke care and advanced brain and spinal cord surgery, as
well as transportation to hospitals and medical facilities recognized nationally
for excellence in their respective fields. We also respond to requests by
managed care companies who need to transport a patient to a facility within
their network.

Based in Denver, Colorado, and Clearwater, Florida, Air Response maintains
an aircraft fleet, which includes 15 owned and two leased aircraft. Air Response
has the competitive advantage generated by the long-range capabilities of its
Model 36 Learjets offering worldwide, intercontinental response capabilities. It
also has the added advantage of an in-house maintenance team, providing
expedient flight readiness equipped with state-of-the-art medical equipment
including the lifeport stretcher system, oxygen, suction pumps, compressed air
and a 1,500 watt AC inverter.

PHARMACEUTICAL SERVICES SEGMENT.

During 1999, our pharmaceutical services segment accounted for 12.4% of
consolidated revenues from operations.

In April 1998, we acquired Pharmacy Care Specialists, Inc. ("PCS"), a
closed network pharmacy employing approximately 60 individuals with its
principal place of business in Lakeland, Florida. Through PCS we provide
unit-dosed medications to over 4,500 residents in sixty-eight assisted-living
facilities across Florida. We deliver medications to the facilities, provide
training workshops and third party billing.

We believe the future of the pharmacy industry is in a transitional phase,
and that the area with the most potential growth is in the assisted-living
facilities, mail order and Internet pharmacy services. The insurance industry
has, in recent years, expanded its involvement with mail order pharmacies. In
essence, many insurance companies are requiring their policyholders to order, by
mail, their medications from an approved, contracted pharmacy. This allows them
to control expenses by stipulating the amount each medication will be sold for,
thus allowing them to increase their profit margin.

We have targeted our marketing efforts to accelerate the assisted-living
facility, mail order and Internet business. In late 1999, we launched our online
pharmacy, www.cyber-careshop.com. As the population ages and expands and many of
these older individuals relocate to areas we serve, the market for
pharmaceuticals to assisted-living facilities increases as does the direct-mail
pharmacy market.

SALES AND MARKETING

We market each of our services in various methods, including cross
marketing, customer and physician referrals, reputation in the community and
third parties.

7
<PAGE>
TECHNOLOGY ASSISTED DISEASE MANAGEMENT SEGMENT

Studies now show that 1% of the U.S. population is responsible for 30% of
all healthcare costs and that 1/3 to 1/2 of those costs are preventable through
monitoring and intervention. We have created an Internet-based healthcare
delivery system for these high-cost, chronically ill patients which would
dramatically improve patient health while significantly reducing per-patient
costs. Our customers are expected to be payors, including managed-care companies
and health management organizations, who currently spend an average of
approximately $70,000 per year for the care of each of these patients. We
believe these prospects are highly motivated to reduce costs and will be strong
candidates to purchase our EHC products and services in the future.

We intend to reach these prospects through two separate channels. The
first channel is an indirect channel where we will form partnerships or
alliances with companies who have relationships with customers we have targeted.
The second channel will use our direct sales force to contact the largest of
these payors and providers. State Medicaid and indigent care organizations, the
military, Veterans' Administration, and major managed care organizations are a
sample of those prospects.

We also believe that our agreements with Nortel, Healthlink Group, the
Mayo Clinic, SIIC Medical and the other companies, will increase our brand
recognition and revenues.

PHYSICAL THERAPY AND REHABILITATION SERVICES SEGMENT

Our physical therapy and rehabilitation business relies upon community
reputation, customer referral, physician and medical resource referrals and
payor sources. We identify market areas to expand in and open new clinics based
on our experience and market demographics.

INTERNATIONAL AIR AMBULANCE TRANSPORT SEGMENT

Our air ambulance transport business relies upon print media, yellow page
advertising, independent brokers, personal contacts, managed care and physician
referrals to attract new customers. We also staff exhibit booths at major
industry-specific conventions to attract hospital groups, insurance companies,
assistance companies, and managed care organizations.

PHARMACEUTICAL SERVICES SEGMENT

We have targeted our marketing efforts to accelerate the assisted-living
facility, mail order and Internet business. As the population ages and expands
and many of these older individuals relocate to areas we serve, the market for
pharmaceuticals to assisted-living facilities increases as does the direct-mail
pharmacy market. Currently, we have concentrated on central and west Florida.

EMPLOYEES

As of March 28, 2000, we employed approximately 528 persons, of which
approximately 481 are full time. Our ability to provide our services is
dependent upon our recruiting, hiring and retaining qualified technical
personnel. To date, we have been able to recruit and retain sufficient qualified
personnel. None of our employees are represented by a labor union. We have not
experienced any work stoppages and consider our relations with our employees to
be good.

8
<PAGE>
COMPETITION

The healthcare industry in general and the market for medical ancillary
services are highly competitive. We compete with companies that are larger in
size and have access to considerably greater financial resources than we do. We
compete by providing more personalized care to the patients they serve, as well
as providing patient transportation and pharmaceutical delivery.

TECHNOLOGY ASSISTED DISEASE MANAGEMENT SEGMENT

The primary competitors for products produced by CyberCare Technologies
are small, privately-held companies, and none have established a major market
position as of this time. Key differentiatons between our competitors and us in
this segment lie primarily in the network architecture utilizing the Internet we
have built to serve this market. Unlike our known competitors, we are unique in
the automatic collection, transmission, and logging of vital signs measurements
to a central database where the information can be viewed by a caregiver on a
real-time basis or whenever necessary. Known competitive systems require the
manual entry of information. We believe we are unique in using TCP/IP protocols
for the transmission of medical data in a two-way interactive voice and video
session between patients and caregivers. Our patented, proprietary technology
based on patented technology puts us in a very favorable competitive position.

PHYSICAL THERAPY AND REHABILITATION SERVICES SEGMENT

In the physical therapy and rehabilitation industry, there are thousands
of treatment centers, organizations, clinics and facilities some of which are
larger in size than we are and which have access to considerably greater
financial resources than we do.

INTERNATIONAL AIR AMBULANCE TRANSPORT SEGMENT

The air ambulance transport business has numerous smaller competitors with
short-range aircraft, but has limited competitors with aircraft capability of
performing international and, in particular, trans-Atlantic flights. Medjet in
Alabama, Kalitta in Detroit, and Sky Service in Toronto are the biggest
competitors in the international market.

PHARMACEUTICAL SERVICES SEGMENT

Our pharmacy business competes directly in the sale and delivery of
prescription drugs to individuals living in adult living facilities. There are
numerous competitors larger in size than we are which have access to
considerably greater financial resources. We rely on reputation and service to
market our services.

GOVERNMENT REGULATION

GENERAL

The Health Insurance Portability and Accountability Act of 1996 mandates
the use of standard transactions, standard identifiers, security and other
provisions by the end of year 2000. Regulations have been proposed to implement
these requirements, and we are designing our applications to comply with the
proposed regulations. However, until these regulations become final, possible
changes in these regulations could cause us to use additional resources and lead
to delays as we revise our operations.

9
<PAGE>
To our knowledge, and other than what we have described in this statement
and other than occupational health and safety laws and labor laws which are
generally applicable to most companies, our products are not subject to
governmental regulation by any federal, state or local agencies that would
affect the manufacture, sale or use of our products. We cannot, of course,
predict what sort of regulations of this type may be imposed in the future, but
we do not anticipate any unusual difficulties in complying with governmental
regulations which may be adopted in the future.

We have not incurred costs associated with environmental laws and do not
anticipate such laws will have any significant effect on our future business.

TECHNOLOGY ASSISTED DISEASE MANAGEMENT SEGMENT

Our CyberCare Technologies products are subject to regulation by the Food
and Drug Administration ("FDA"). We filed for 510-K approval with the FDA in
January 2000. Since we use vital signs measuring devices which are already
approved by the FDA, we believe that obtaining this approval for our products
will be accomplished within approximately 120 days from the time application was
made. Complying with FDA regulations is time consuming, burdensome and
expensive, and we could be delayed or prevented from introducing our CyberCare
Technologies' products and services. This could have a material adverse affect
on our business.

PHYSICAL THERAPY AND REHABILITATION SERVICES SEGMENT

Our physical therapy and rehabilitation business are subject to extensive
federal and state regulations related to fee limitations, quality control
requirements and accounting and cost tracking requirements. These operations are
subject to periodic review and inspection of facilities, patient records and
billing policies which, if the applicable regulatory agency finds deficiencies,
may result in reduction or stoppage of reimbursements and/or fines and
penalties. Additionally, these operations are subject to severe restrictions
relative to referrals from and compensation to physicians as provided by the
Federal Stark rules and Florida Self-Referral rules. Violations of any of these
rules can result in penalties and fines and some cases criminal sanctions.

INTERNATIONAL AIR AMBULANCE TRANSPORT SEGMENT

Our air ambulance transport business is subject to significant federal and
international government regulations relating to airline safety, capital
requirements, licensing, maintenance, scheduling, and similar aspects of our
operations. Due to the nature of aircraft operations, applicable regulations and
our policy, we incur substantial expenses associated with the maintenance of our
aircraft fleet. Although we believe that our current operations comply with
applicable regulations, there can be no assurance that the subsequent adoption
of laws or interpretations of existing laws will not regulate, restrict or
otherwise adversely affect our business.

PHARMACEUTICAL SERVICES SEGMENT

Our pharmacy business is also subject to extensive federal and state
regulations, many of which are specific to pharmacies and the sale of
over-the-counter drugs. Regulations in this area often require subjective
interpretation, and we cannot be certain that our attempts to comply with these
regulations will be deemed sufficient by the appropriate regulatory agencies.
Violations of any of these regulations could result in various civil and
criminal penalties, including suspension or revocation of our licenses or
registrations, seizure of our inventory, or monetary fines, which could
adversely affect our operations. As we expand our product and service offerings,
more of our products and services will likely subject to regulation by the FDA,
which regulates drug advertising and promotion. Complying with FDA regulations
is time consuming, burdensome and expensive, and could delay our introduction of
new products and services.

10
<PAGE>
RISK FACTORS

THE HEALTHCARE INDUSTRY IS SUBJECT TO EXTENSIVE LAWS AND REGULATIONS, WHICH
COULD IMPAIR OUR ABILITY TO CONDUCT BUSINESS.

The healthcare industry in general and the medical ancillary service
business in particular is subject to extensive federal, state and local
regulation relating to licensure, conduct of operations, ownership of
facilities, environment rules, pricing and reimbursement policies. Although we
believe that our current operations comply with applicable regulations, we
believe that the healthcare industry will continue to change, requiring us to
modify our agreements and operations from time to time. While we believe that we
will be able to structure our agreements and operations in accordance with
applicable law, there can be no assurance that the subsequent adoption of laws
or interpretations of existing laws will not regulate, restrict or otherwise
adversely affect our business.

WE HAVE A HISTORY OF LOSSES AND A SUBSTANTIAL ACCUMULATED DEFICIT.

To date we have been unable to generate revenue sufficient to be
profitable on a consistent basis. Consequently, we have sustained substantial
losses. Net losses for the years ended December 31, 1999 and 1998 were
$10,808,451 and $7,380,953, respectively. As of December 31, 1999, we had
working capital of $12,825,611, as compared to a working capital deficiency of
$2,319,060 as of December 31, 1998. Accumulated deficit for the years ended
December 31, 1999 and 1998 were $(38,451,795) and $(27,643,344), respectively.
There can be no assurance that we will ever achieve the level of revenues needed
to be profitable in the future or, if profitability is achieved, that it will be
sustained.

WE ARE A RAPIDLY EXPANDING COMPANY AND HAVE ALL OF THE RISKS ASSOCIATED WITH A
GROWING COMPANY.

We intend to grow through internal growth acquiring healthcare
technologies and e-commerce businesses and developing strategic joint ventures.
There can be no assurance that suitable acquisitions or joint venture partners
will be available or that acquisitions or joint venture agreements can be
negotiated on acceptable terms, or that the operations of acquired businesses
can be integrated effectively into our operations. Competition for suitable
acquisition candidates is expected to be intense and many of our competitors
will have greater resources than we have. Our failure to implement our business
strategy could have a material adverse effect on our financial performance and,
moreover, the attendant risks of expansion could also have a material adverse
effect on our business.

Our recent acquisition, CyberCare Technologies is in the development stage
and has incurred net losses to date due primarily to research, development and
start-up costs. We expect it will continue to have losses in 2000, and will
require a significant amount of capital to bring its products and services to
market. There can be no assurance that CyberCare Technologies will be profitable
in the future or that it can be successfully integrated into our operations. Our
growth strategy is to give primary emphasis to this technology business and
reduce the importance and/or eliminate our other business segments. This will
result in significant additional demands on our infrastructure, and will place a
significant strain on our management, administrative, operational, financial and
technical resources, and increased demands on our systems and controls.
Additional capital may be needed and there can be no assurance that we will be
able to obtain sufficient resources to support CyberCare Technologies and future
acquisitions and growth.

The inability to continue to upgrade the operating and financial control
systems, the emergence of unexpected expansion difficulties or failure to manage
our proposed expansion properly could have a material adverse effect on our
business, financial condition and results of operations. The laws and
regulations applicable to financial arrangements in the healthcare industry are
complex and may be subject to varying interpretations.

11
<PAGE>
WE MAY NOT BE ABLE TO PROTECT OUR PATENTS AND PROPRIETARY TECHNOLOGY, WHICH
COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS.

Our ability to compete effectively in the healthcare technologies and
e-commerce industry will depend on our success in developing and marketing our
products and services and/or acquiring other suitable medical e-commerce
businesses and protecting their proprietary technology, both in the United
States and abroad. The patent positions of CyberCare Technologies generally
involve complex legal and factual questions.

We currently have an exclusive license for one patent issued and one
pending with regard to our healthcare e-commerce technology. We intend to file
for additional patents under our license agreement on products for which we feel
the cost of obtaining a patent is economically reasonable in relation to the
expected protection obtained and has economic benefit. There can be no
assurances that any patent that we apply for will be issued, or that any patents
issued will not be challenged, invalidated, or circumvented, or that the rights
granted thereunder will provide any competitive advantage. We may incur
substantial costs in defending any patent or license infringement suits or in
asserting any patent or license rights, including those granted by third
parties, the expenditure of which we might not be able to afford.

Although we have and will continue to enter into confidentiality and
invention agreements with our employees and consultants, there can be no
assurance that such agreements will be honored or that we will be able to
adequately protect our rights to our non-patented trade secrets and know-how.
Moreover, there can be no assurance that other individuals or entities will not
independently develop substantially equivalent proprietary information and
techniques or otherwise gain access to our trade secrets and know-how.

IF WE ARE UNABLE TO ACQUIRE LICENSES TO USE PATENTS OR OTHER PROPRIETARY RIGHTS
THAT ARE NECESSARY TO THE PRODUCTION AND DEVELOPMENT OF OUR PRODUCTS OR
SERVICES, OUR BUSINESS MAY BE ADVERSELY EFFECTED.

In addition, we may be required to obtain additional licenses, patents or
other proprietary rights from third parties. There can be no assurance that any
licenses required under any patents or proprietary rights would be made
available on acceptable terms, if at all. If we do not obtain required licenses,
we could encounter delays in product development or find that the development,
manufacture, or sale of products requiring such licenses could be foreclosed.
Additionally, we may, from time to time, support or otherwise collaborate in
research conducted by universities and governmental research organizations.
There can be no assurance that we will have or be able to acquire exclusive
rights to the inventions or technical information derived from such
collaborations or that disputes will not arise with respect to rights in
derivative or related research programs conducted by us or such collaborators.

THE MARKETABILITY OF OUR EHC PRODUCTS IN THE UNITED STATES AND ELSEWHERE WILL BE
MATERIALLY ADVERSELY AFFECTED IF WE DO NOT RECEIVE 510-K APPROVAL OF THESE
PRODUCTS FROM THE FDA.

In January 2000, we applied with the FDA for 510-K approval of our EHC
products, which if granted, will allow us to market and sell our products in the
United States. If we do not receive 510-K approval from the FDA, our ability to
market and sell our EHC products in the United States and elsewhere will be
materially adversely affected.

WE CANNOT GUARANTEE OUR PRODUCTS WILL BE FULLY DEVELOPED OR ACCEPTED BY THE
MARKETS.

Due to the early-stage development of our healthcare technology and
e-commerce products and services, no assurance can be given that these products
or services can be developed into commercial products, manufactured on a large
scale or be economical to market. Nor can there be any assurance that these
products or services will achieve or sustain market acceptance. There is,
therefore, substantial risk that our product and service development and
commercialization efforts will not prove to be successful.

12
<PAGE>
There can be no assurance that physicians, medical providers or the
medical community in general will accept and utilize our products and services.
The extent that, and rate of which, these products achieve market acceptance and
penetration will depend on many variables including, but not limited to,

o a timely penetration of the market;
o the establishment and demonstration in the medical community of the
clinical safety;
o efficacy and cost-effectiveness of these products and services;
o the advantage of these products over existing technology;
o third-party reimbursements practices and our manufacturing; and
o quality control, marketing and sales efforts.

There can be no assurance that the medical community and third-party
payors will accept our technology or services to become commercially feasible.
Similar risks will confront any other products and services we develop in the
future. Failure of our products and services to gain market acceptance would
have a material adverse effect on our business, financial condition, and results
of operations.

OUR LIMITED MARKETING AND SALES RESOURCES COULD PREVENT US FROM EFFECTIVELY
MARKETING OUR PRODUCTS AND SERVICES.

We have limited internal marketing and sales resources and personnel. In
order to market any products and services we may develop, we will have to expand
our marketing and sales force with technical expertise and distribution
capability, or outsource such duties to independent contractors or rely upon
strategic partnership relationships. There can be no assurance that we will be
able to establish sales and distribution capabilities or that we will be
successful in gaining market acceptance for any products or services we may
develop. There can be no assurance that we will be able to recruit and retain
skilled sales, marketing, service or support personnel, that agreements with
distributors will be available on terms commercially reasonable to us, or at
all, or that our marketing and sales efforts will be successful.

Failure to successfully establish a marketing and sales organization,
whether directly or through third parties, would have a material adverse effect
on our business, financial condition, cash flows, and results of operations. To
the extent that we arrange with third parties to market our products or
services, the success of such products and services may depend on the efforts of
such third parties. There can be no assurance that any of our proposed marketing
schedules or plans can or will be met.

THE NATURE OF OUR BUSINESS EXPOSES US TO PROFESSIONAL AND PRODUCT LIABILITY
CLAIMS, WHICH COULD MATERIALLY ADVERSELY IMPACT OUR OPERATIONS.

Our business and e-commerce technology exposes us to potential
professional and product liability risks, which are inherent in such businesses
and products. There can be no assurance that we will not be subjected to future
claims and potential liability. While we plan to maintain insurance against
professional and product liability and defense costs, there can be no assurance
that claims against us arising with respect to our products or services will be
successfully defended or that the insurance to be carried by us will be
sufficient to cover liabilities arising from such claims. A successful claim
against us in excess of our insurance coverage could have a material adverse
effect on us. Furthermore, there can be no assurance that we will be able to
continue to obtain or maintain liability insurance on acceptable terms.

THE LOSS OF CERTAIN MEMBERS OF OUR MANAGEMENT TEAM COULD MATERIALLY ADVERSELY
AFFECT OUR BUSINESS.

We will be dependent to a significant extent on the continued efforts and
abilities of our Chairman, Michael Morrell, and other key employees.
Notwithstanding our ownership of a one million dollar key-man life insurance
policy on each of Mr. Morrell and our President, Mr. Paul C. Pershes, if we were
to lose the services of either individual or other key employees before a
qualified replacement could be obtained, our business could be materially
adversely affected.

13
<PAGE>
THERE IS ONLY A VOLATILE LIMITED MARKET FOR OUR COMMON STOCK.

The market for our securities is highly volatile. The closing price of our
common stock during 1999 has fluctuated widely. The stock markets have in
general, and technology companies in particular, experienced extreme stock price
volatility. It is likey that the price of our common stock will continue to
fluctuate widely in the future.

FORWARD LOOKING STATEMENTS

Some of the statements contained in this Form 10-KSB for Cyber-Care, Inc.,
discuss future expectations, contain projections of results of operations or
financial condition or state other forward-looking information. All references
to we, our, or us refers to Cyber-Care, Inc. or to Cyber-Care, Inc. and its
consolidated subsidiaries, as applicable. These statements are subject to known
and unknown risks, uncertainties, and other factors that could cause the actual
results to differ materially from those contemplated by the statements. The
forward-looking information is based on various factors and is derived using
numerous assumptions. Important factors that may cause actual results to differ
from projections include, for example:

o the success or failure of management's efforts to implement their
business strategy;

o our ability to protect our intellectual property rights;

o our ability to compete with major established companies;

o the effect of changing economic conditions;

o our ability to attract and retain quality employees; and

o other risks which may be described in future filings with the SEC.

ITEM 2. DESCRIPTION OF PROPERTY

We believe our various facilities are adequate to meet our current
business needs, and that our properties are adequately covered by insurance.

14
<PAGE>
We lease approximately 7,300 sq. ft. of office space in Boynton Beach,
Florida for our corporate offices at an average monthly net rental of $8,589
over the term of the lease. The lease expires in May 2004.

CyberCare Technologies operated in leased space at the Advanced Technology
Development Center which is located on the campus of the Georgia Institute of
Technology in Atlanta, Georgia ("Georgia Tech"). The engineers at Georgia Tech
who provide services for CyberCare Technologies are located at the Georgia
Center for Advanced Telecommunications Technology where CyberCare Technologies
also maintains a demonstration facility. We entered into a new lease for
approximately 9,671 square feet of office space in Atlanta, Georgia. The lease
is for five years and the monthly rental is approximately $10,000. Our sleep
apnea business leases approximately 2,600 sq. ft. of space for its sleep
disorder center in Tallahassee, Florida for a total net monthly rental of
$3,007. The lease expires March 31, 2001.

Our rehabilitation and therapy businesses lease approximately 142,500 sq.
ft. of space for its 95 rehabilitation centers located throughout Florida for a
total monthly net rental of approximately $125,915. The leases expire
periodically through December 2003.

Our air ambulance transport business leases office and hangar space in
Clearwater, Florida at an average monthly net rental of $4,350 on a
month-to-month basis and leases approximately 37,000 sq. ft. of office and
hangar space in Denver, Colorado; Schenectady, New York; and Illinois for a
total current net monthly rental of $16,218. The leases expire through June 30,
2002.

Our pharmaceutical services business leases 15,000 square feet of office
and warehouse space in Lakeland, Florida. The lease term is for five years with
an option to renew for an additional five years and a monthly rental of
approximately $5,100. The lease expires July 1, 2004.

ITEM 3. LEGAL PROCEEDINGS

We are not presently a party to any material litigation outside the
ordinary course of business.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

15
<PAGE>
PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED SHAREHOLDER MATTERS

The following table sets forth the high and low reported sales prices per
share of our common stock as reported on the Nasdaq SmallCap Market for the
fiscal years ended December 31, 1999 and the fiscal years ended December 31,
1998.

FISCAL 1999
-----------
HIGH LOW
----- ----
First Quarter $1.69 $.63
Second Quarter 2.38 .69
Third Quarter 2.38 .75
Fourth Quarter 11.19 1.69

FISCAL 1998
-----------
HIGH LOW
----- -----
First Quarter $2.13 $1.25
Second Quarter 2.19 1.38
Third Quarter 1.88 .41
Fourth Quarter 1.00 .28

On March 24, 2000, the last bid price of our common stock as reported on
the Nasdaq SmallCap Market was $19. We believe that as of March 24, 2000, there
were approximately 536 record owners of our common stock and 25,000 beneficial
holders of our common stock.

It is our present policy not to pay cash dividends and to retain future
earnings to support our growth. Any payment of cash dividends in the future will
be dependent upon the amount of funds legally available therefor, our earnings,
financial condition, capital requirements and other factors that our board of
directors may deem relevant. We do not anticipate paying any cash dividends in
the foreseeable future.

RECENT SALES OF UNREGISTERED SECURITIES

The following information sets forth information for all securities sold
from October 1, 1999 to present, without registration under the Act, that have
not been reported in prior 10-QSBs.

During 1999, pursuant to a private placement, we sold $7,345,000 of 10%
subordinated convertible debentures (the "10% debentures") together with
3,672,500 three-year warrants at exercise prices ranging from $1.11-$1.50, with
the majority at $1.25 per share. During 1999, $1,225,000 of the 10% convertible
debentures were converted into shares of common stock. The 10% debentures had an
outstanding balance of $6,120,000 at December 31, 1999. We believe the above
transactions were exempt from registration pursuant to Section 4(2) of the
Securities Act, as the issuances were to accredited investors, and since the
transactions were non-recurring and privately negotiated.

16
<PAGE>
In December 1999, we, pursuant to a qualified investor placement
("QIP"), sold $14,325,000 of 10% subordinated convertible debentures together
with 1,705,366 detachable warrants which are exercisable at $4.20 per share at
any time within six years from the date of grant. The debentures are convertible
at $3.50 per share and can be converted from date issued. The entire balance of
these debentures was outstanding as of December 31, 1999.

On February 28, 2000, we sold, through a QIP, received $11 million, less
underwriters' fees, 500,000 shares of our common stock at $22 per share. We
believe the above transaction was exempt from registration pursuant to Section
4(2) of the Securities Act, as the issuance was to one accredited investor, and
since the transactions were non-recurring and privately negotiated.

CYBR has entered into an agreement with the parent of SIIC Medical,
Shanghai Industrial Holdings Inc. ("SIHL") (Hong Kong Main Board: 363) to sell
to SIHL 1,500,000 shares of our common shares at $16.30 per share. CYBR, in
turn, will purchase 7.7 million shares of SIHL at $1.96 US per share. We believe
the above transaction was exempt from registration pursuant to Section 4(2) of
the Securities Act, as the issuance was to an accredited investor, and since the
transaction was non-recurring and privately negotiated.

ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

INTRODUCTION

Management's Discussion and Analysis of Financial Condition and Results of
Operations is presented on the following pages. The principal purpose of this
review is to provide the reader of the attached financial statements and
accompanying footnotes with a detailed analysis of the financial results of
Cyber-Care, Inc. ("Cyber-Care"). Among other things, this discussion provides
commentary on Cyber-Care's history, business philosophies, and operations by
business segment.

STRATEGY

In August 1999, we acquired CyberCare, Inc. ("CyberCare Technologies")
which was developing an Internet-based solution and interactive system providing
EHC System products and network services to support remote delivery of care,
patient monitoring and education to the United States and worldwide healthcare
markets. We subsequently acquired certain assets of Help Innovations, Inc. which
provided additional technology and an application and a library of computerized
disease management protocols that will assist us in delivering services through
the Internet.

We also identified the physical therapy and rehabilitation field as a
target and acquired three companies resulting in our becoming the largest
physical therapy and rehab company in Florida today.

We are currently reviewing and developing our long-term strategy with our
Board of Directors to focus our energies on expanding our business as follows:

17
<PAGE>
o Primary focus will be the development of the EHC system products and Internet
technology services on a worldwide basis.

o Continue to operate the air ambulance business to increase revenues,
profitability and create synergies for our technology business. We will look
for an appropriate buyer, or spin off the company to existing shareholders
when appropriate, retaining a relationship with the new company, to add value
and revenue to our Internet based technology business.

o Continue to operate our pharmacy business, find an appropriate company for
our institutional pharmacy business and, if possible, enter into a strategic
alliance to provide e-pharmacy business through our Electronic HouseCall
System. We could eventually sell this business to the strategic partner.

SIGNIFICANT ACCOUNTING POLICIES

REVENUE

We recognize revenue at the time the service is provided. Medicare and
Medicaid reimbursements are recognized based on allowable charges. The
difference between our established billing rates and contracted or anticipated
reimbursement rates is recorded as a contractual allowance and offset against
net sales. These revenues are subject to audit and retroactive adjustment by the
respective Medicare and Medicaid fiscal intermediaries. We do not believe that
retroactive adjustments, if any, would be material to our financial statements.

GOODWILL AND LICENSES

We record goodwill at cost and amortize it using the straight-line method
over twenty-five years.

Licenses, which primarily consist of medical technology and other
licenses, are recorded at cost and are amortized using the straight-line method
over ten to seventeen years.

We periodically evaluate the recovery of the carrying amount of
intangibles by determining if any impairment indicators are present. These
indicators include management's plans for the division, income derived from
businesses acquired and other factors. If this review indicates that intangibles
will not be recoverable, as principally determined based on the estimated
undiscounted cash flows of the entity over the remaining amortization period,
our carrying value of the intangibles is reduced by the amount the carrying
value exceeds its fair value.

During 1998, the board of directors reviewed the operations and the
financial condition of its physician practice and our management consulting
subsidiary and closed them in September 1998. As a result of this decision,
management has written-off $2,354,476 of goodwill related to these companies.

INVESTMENT IN MARKETABLE EQUITY SECURITIES

In 1999, we accounted for our investment in Westmark Group Holdings, Inc.,
a public company, on the cost method of accounting, since we reduced holdings
below 20%. We have adjusted the investment to its fair

18
<PAGE>
market value as of December 31, 1999 and reflected an unrealized loss on
marketable securities of $1,768,049, which is included in shareholder's equity.

In 1998, we had a 21% investment in Westmark , and, accordingly accounted
for the investment under the equity method of accounting in 1998. Under the
equity method our share of the net income (loss) of Westmark is recognized as
income (loss) in our statement of operations.

STOCK-BASED COMPENSATION

Beginning in 1996, we implemented the provisions of SFAS 123, Accounting
of Stock-Based Compensation, in accounting for stock-based transactions with
non-employees and, accordingly, records compensation expense in the consolidated
statements of operations for such transactions. We continue to apply the
provisions of APB 25 for transactions with employees, as permitted by SFAS 123.

RESULTS OF OPERATIONS - CYBER-CARE CONSOLIDATED

COMPARISON OF THE RESULTS OF OPERATIONS FOR YEAR ENDED DECEMBER 31, 1999 AND
1998.

Total revenue from operations increased 192% to $39,155,664 for the year
ended December 31, 1999 from $13,430,969 for 1998, primarily driven by increases
in all business segments resulting from acquisitions in the air ambulance and
physical therapy and rehabilitation segments, internal growth from increased
rates and miles flown in the air ambulance business and opening new locations in
the physical therapy and rehabilitaion business.

Cost of services, which includes payroll, materials and other expenses
directly associated with our services increased by $15,427,821, from $5,553,257
in 1998 to $20,981,078 in 1999. As a percentage of revenues from operations,
costs of services increased 278%. The increase resulted from acquisitions in the
air ambulance, and physical therapy and rehabilitation segments and costs
associated with internal growth.

General and administrative expenses increased 65% to $13,739,200 for the
year ended December 31, 1999 from $8,337,762 in 1998. The increase was due to
increased costs associated with internal growth and acquisitions, which included
operating additional locations of the air ambulance business, back office
support staff and supervisory staff.

Operating income (loss) increased to $1,490,275 for the year ended
December 31, 1999 as compared to an operating loss of $1,764,914 for 1998, an
increase of 184%. The results were driven by internal growth, acquisitions, and
gain on sale of a subsidiary. The 1999 results were negatively affected by the
development and startup costs of CyberCare Technologies in the amount of
$3,862,765.

Net loss increased to $10,808,451 for the year ended December 31, 1999 in
comparison to $7,380,953 for 1998. The results were caused primarily the change
for beneficial conversion feature of $8,572,247, interest expense and the
development and startup cost of CyberCare Technologies in the amount of
$3,862,765.

LIQUIDITY AND CAPITAL RESOURCES -- CYBER-CARE

Historically, we have financed our growth from the issuance of common
stock and convertible debentures. In 1999, we raised approximately $21 million
through debt and equity offerings, which we are using for working capital
purposes. Our capital requirements in connection with our current business plan
will continue to be significant through fiscal 2000. We had working capital of
approximately $13 million, as of December 31, 1999. In February 2000, we
completed an $11 million financing, which we intend to use for general working
capital purposes in the CyberCare Technologies segment. In addition, we have
credit facilities of approximately $5.25 million, for which approximately $2.0
million of excess borrowing base was available as of December 31, 1999.

19
<PAGE>
Since we do not generate sufficient revenues to fund our current
operations internally, we will rely on debt or equity offerings in the future.
We anticipate that our current working capital will provide sufficient liquidity
through fiscal 2000. However, we can provide no assurance our ability to fund
operations through fiscal 2000 will be shortened due to factors beyond our
control, such as lower than expected revenues or increased expenses.

As of December 31, 1999, we had current liabilities of approximately $11.4
million, which includes: (a) approximately $3.8 million which consists of three
credit facilities, which accrue interest at rates between 8% and 11.5%; and (b)
approximately $2.0 million which consists of the current portion of our long
term notes payable. In addition, we will owe minimum payments on operating
leases of approximately approximately $1.7 million during fiscal 2000. As of
December 31, 1999, we had long term liabilities of approximately $27.6 million
which includes: (a) approximately $11.5 million of notes payable and long-term
debt, which mature through November 2003; and (b) approximately $15.8 million of
convertible subordinated debentures, which may be converted to common stock at
prices between $.50 and $3.50 per share.

Except for our line of credit, we have no commitment for additional financings
or borrowings. We can provide no assurance that additional debt or equity
financing will be undertaken, and if undertaken will be successful. Lower than
expected earnings resulting from adverse conditions or otherwise, could restrict
our ability to expand our operations, or otherwise fully execute our business
plan.

Our net cash flow from operating activities resulted in deficits of
$3,640,082 and $3,862,280 for the year ended December 31, 1999 and 1998,
respectively. The $222,198 decrease is due primarily to increase in operating
income.

Our net cash used in investing activities for the year ended December 31,
1999 was $2,980,728 as compared to net cash used in investing activities for the
year ended December 31, 1998 of $1,120,748. This is due primarily to an increase
in equipment purchases relating to aircraft.

Our net cash flows from financing activities during the year ended
December 31, 1999 increased by $12,906,684 or 307%, to $17,630,843 from
$4,724,159 during the year ended December 31, 1998. The increase was due
primarily to private placement proceeds received during the year ended December
31, 1999, and net advances on a line of credit.

RESULTS OF OPERATIONS -- TECHNOLOGY ASSISTED DISEASE MANAGEMENT SEGMENT

Technology assisted disease management segment had minimal revenue for the
period. Technology assisted disease management segment has incurred operating
losses of approximately $3,862,764 since acquisition.

RESULTS OF OPERATIONS - PHYSICAL THERAPY AND REHABILITATION SERVICES SEGMENT

Physical therapy and rehabilitation's revenue increased 714%, or
$8,167,672, to $9,311,297, from $1,143,625, driven by the acquisition of YGHN,
effective October 15, 1998 and Carolina effective August 1, 1999, and internal
growth.

Cost of services, which includes payroll, medical supplies, and other
expenses associated with increased revenue increased from $603,255, or 52% of
revenue, in 1998 to $3,318,517, or 36% of revenue in 1999, 450% increase. The
increase was primarily due to increases in revenue by internal growth and
acquisitions. General and administrative expenses for the year ended December
31, 1999 were $4,961,693, or 53.2% of revenue, compared to $582,633 or 50% of
revenue for 1998. The 2.3% increase in such expenses reflects additional
overhead in regards to Carolina, which was a start up from the date of
acquisition, and internal growth. Operating income increased 127.5% or $859,224
to $791,865 for the year ended December 31, 1999, from a prior year loss of
$67,359, reflecting the acquisitions of YGHN, Carolina and internal growth.

RESULTS OF OPERATIONS - INTERNATIONAL AIR AMBULANCE TRANSPORT SEGMENT

20
<PAGE>
International air ambulance transport's revenue increased 195%, or
$13,908,881, to $21,055,338 for the year ended December 31, 1999, from
$7,146,457 in 1998, driven by the acquisition of Air Response, effective March
1, 1999, and internal growth resulting from increased rates, utilization of
aircraft and miles flown. Cost of services, which includes fuel, maintenance,
payroll and other expenses directly associated with our services increased from
$3,124,980, or 22% of revenues, in 1998 to $14,478,770, or 69% of revenues, in
1999. General and administrative expenses increased 20% to $2,906,379 for the
year ended December 31, 1999 from $3,389,914 for the 1998 period. Net income
increased 146.5% or $1,430,380 to $454,610 for the year ended December 31, 1999,
reflecting the acquisition of Air Response, increased rates, and miles flown and
decrease in overall operating costs, as a percentage of revenue, due to
synergies.

RESULTS OF OPERATIONS - PHARMACY SEGMENT

Pharmacy's revenue increased 83.5%, or $2,144,746, to $4,710,633 for the
year ended December 31, 1999 compared to $2,565,887 for 1998. The increase
reflects three additional months of activity over 1998 and substantial internal
growth resulting from adding additional adult living facilities and customers.
Cost of services, which includes pharmaceutical supplies, payroll, and other
expenses directly associated with our services increased from $1,648,481, or
64.2% of revenue in 1998 to $3,074,446, or 65.2% of revenue, in 1999. General
and administrative expenses for the year ended December 31, 1999 were
$1,553,353, or 32.0% of revenue, compared to $869,200, or 33.9% of revenue, for
1998. Operating losses decreased 75%, or $10,759, to $3,514 for the year ended
December 31, 1999, compared to $14,273 in 1998, reflecting increase in gross
margins and decrease in operating costs as a percentage of revenue.

ITEM 7. CONSOLIDATED FINANCIAL STATEMENTS

The Company's consolidated financial statements and the reports of
independent accountants thereon appear beginning on Page F-2. See index to
consolidated financial statements on Page F-1.

ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE

Ernst and Young, LLP was engaged, on June 1, 1999, as the Company's
independent certified public accountants.

Grant Thornton, LLP ("Grant Thornton") declined to stand for
reelection as the Company's, (a Florida corporation), independent certified
public accountants effective May 20, 1999.

The decision to change accountants was approved by the Company's Board
of Directors.

Grant Thornton's report on the financial statements, for each of the
last two years, contained no adverse opinion, disclaimer of opinion and was
not qualified or modified as to uncertainty, audit scope or accounting
principles.

There were no disagreements and no reportable events between the
Company and Grant Thornton on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedures
in connection with the audits of the fiscal years ended December 31, 1998
and 1997 and for the interim through the date of resignation, May 20, 1999.

21
<PAGE>
PART III

ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT

Our current directors and executive officers are as follows:

NAME AGE POSITION
- ---- --- --------
Michael F. Morrell 57 Chairman of the Board,
Chief Executive Officer, and
Director

Paul C. Pershes 56 Director and President

Linda Moore 46 Senior Vice President and
Secretary

Arthur Kobrin 38 Senior Vice President and
Chief Accounting Officer

John Haines 52 Director and Senior Vice
President

Daniel Bivins, Jr. 43 Senior Vice President

Theodore J. Orlando 59 Director

Glen Barber 49 Director

Robert Coleman 64 Director

Terry Lazar 56 Director

Dana Pusateri 46 Director

Louis R. Capece, Jr. 51 Director

MICHAEL F. MORRELL has served as our chairman and chief executive officer
since August 1996. From November 1995 to August 1996, Mr. Morrell was an
independent consultant specialized in the field of corporate finance. From March
1994 to November 1995, Mr. Morrell served as president and a director of
Westmark Group Holdings, Inc. From March 1984 through March 1994, Mr. Morrell
founded and served as president of Nexus Leasing Corp. and Nexus Realty,
entities involved in leasing and real estate investments. From 1966 to 1984, Mr.
Morrell served in executive management positions with Reliance Group Holdings, a
multi-billion dollar provider of insurance, leasing and other services.

PAUL C. PERSHES has served as a director since August 1996 and as our
president since May 1997. Before joining us, Mr. Pershes founded and served as
an officer of Weinberg, Pershes & Company, P.A., an accounting firm, from July
1994 to May 1997. Before founding Weinberg, Pershes & Company, Mr. Pershes was a
senior partner of the international accounting firm Laventhol and Horvath for 18
years, with extensive experience in healthcare.

22
<PAGE>
LINDA MOORE has served as our senior vice president and secretary since
January 1996. From March 1994 through December 1995, Ms. Moore served as senior
vice president and secretary of Westmark Group Holdings, Inc. From 1986 to 1994,
Ms. Moore served as an executive officer of Moore Financial Services, Inc., a
financial public relations firm she founded in 1986.

ARTHUR KOBRIN has served as our senior vice president of financial
operations and chief accounting officer since June 1997. From August 1987 to
June 1997, Mr. Kobrin was employed by Weinberg, Pershes & Company, P.A.

JOHN E. HAINES has served as senior vice president in charge of technology
since September 1999, and has served as a director since August 1999. Mr. Haines
has served as chairman, chief executive officer and president of our subsidiary,
CyberCare, Inc., since its inception in October 1997. Mr. Haines founded C-Med
Corporation, a telemedicine technology company in Atlanta, Georgia, in January
1994, and served as its chief executive officer from its inception until March
1995, when he became chief executive officer of Video Lan Technologies, Inc. Mr.
Haines remained chief executive officer of Video Lan Technologies, Inc. until
December 1995.

DANIEL BIVINS, JR. has served as senior vice president and in house
counsel since November 1999. Mr. Bivins was President of Federal Property
Management Corporation and President of Horizon Holding Company from 1993 to
1999.

THEODORE J. ORLANDO has served as a director since March 1997. In 1994,
Mr. Orlando founded and is currently president of Barkus Capital Resources,
Ltd., a real estate and securities investment company. From 1984 to 1994 he
founded and served as chairman and chief executive officer of TJ Systems
Corporation, a computer leasing company.

GLEN BARBER has served as a director since April 1997. In 1988, Mr. Barber
founded, and is currently president of New Age Communications, Inc., a master
distributor of operator services. Since 1993, Mr. Barber has served as president
and director of the Museum of Art in Tallahassee, Florida.

ROBERT COLEMAN has served as an outside director since December 1999.
Prior thereto, Mr. Coleman has been a private investor. Mr. Coleman was formerly
an officer of Allan & Company, Inc., and a partner of Carlisle and Jacquelin, a
member of the New York Stock Exchange.

TERRY LAZAR has served as an outside director since April 1997. In 1977,
Mr. Lazar founded, and is currently senior partner of, Lazar, DeThomasis,
Sanders and Company, LLP, a full-service accounting firm specializing in
healthcare and other industries.

DANA PUSATERI has served as a director since January 1999. Mr. Pusateri
founded IntegraCare, Inc. in 1988 and served as its chairman, chief executive
officer and president, through November 1995. IntegraCare contracts with skilled
nursing facilities, hospitals and home health agencies to provide physical,
occupational and speech therapy services and owned outpatient clinics. In August
1995, IntegraCare completed a merger with Integrated Health Services, Inc. In
December 1995, Mr. Pusateri left to pursue other consulting opportunities and in
May 1997, Mr. Pusateri co-founded one of our subsidiaries, Your Good Health
Network, Inc., and currently serves as its chief executive officer.

LOUIS CAPECE, JR. has served as a director since March 1999 and president
of one of our subsidiaries, Air Response, Inc., since its inception in 1986.
From 1982 to 1997, Mr. Capece was president of Response Medical, a ground
ambulance company, which serviced a large portion of upstate New York with
emergency ambulance and invalid coach service.

Our officers are appointed annually by the board of directors and serve at
the discretion of the Board. Our directors hold office until the next annual
meeting of shareholders and until their successors have been duly elected and
qualified. Messrs. Barber, Lazar, and Pershes are members of the audit committee
and Messrs. Lazar, Orlando, Pusateri and Pershes are members of the compensation
committee. Michael Morrell and Linda Moore are husband and wife. There are no
other family relationships among any of our directors and executive officers.

23
<PAGE>
SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires our
officers, directors, and persons who own more than ten percent of our common
stock, to file with the SEC initial reports of ownership on Form 3 and reports
of changes in ownership of our common stock and other equity securities on Form
4 and/or Form 5. To our knowledge, based solely on review of the copies of such
reports furnished to us, and representations that no other reports were
required, during the fiscal year ending December 31, 1999, all Section 16(a)
filing requirements were complied with except that reports for the following
executive officers and directors were not filed in a timely manner in the years
indicated:

Glen Barber failed to timely file three Form 4s reporting nine
transactions during 1999 and two Form 5s reporting two transactions in 1997 and
one transaction occurring in 1998. Mr. Barber reported the above transactions
and one other transaction on a Form 5 filed late on March 23, 2000. Daniel
Bivins failed to timely file a Form 3 upon becoming a executive officer in
November of 1999. Mr. Bivins reported his holdings on a Form 5 filed late on
March 23, 2000. Louis Capece failed to timely file a Form 3 upon becoming an
executive officer in March 1999. Mr. Capece reported his holdings on a Form 5
filed late on March 23, 2000. Robert Coleman failed to timely file a Form 3 upon
becoming an executive officer in December 1999. Mr. Coleman reported his
holdings on a Form 5 filed late on March 23, 2000. John Haines failed to timely
file a Form 3 upon becoming an executive officer and director in September 1999.
Mr. Haines reported his holdings on a Form 5 filed late on March 23, 2000.
Arthur Kobrin failed to timely file two Form 4s reporting five transactions, and
one Form 5 reporting one transaction. Mr. Kobrin reported these six
transactions, and one other transaction, on a Form 5 filed late on March 23,
2000. Terry Lazar failed to timely file a Form 4 reporting one transaction in
1999, a Form 5 reporting one transaction in 1998, and a Form 5 reporting two
transactions in 1997. Mr. Lazar reported the above transactions and five other
transactions, three of which occurred in December, on a Form 5 filed late on
March 23, 2000. Linda Moore failed to timely file two Form 4s reporting six
transactions occurring in 1999, a Form 5 reporting one transaction in 1997, and
a Form 5 reporting one transaction in 1998. Ms. Moore reported the above
transactions and two other transactions on a Form 5 filed late on March 23,
2000. Michael Morrell failed to timely file two Form 4s reporting seven
transactions occurring in 1999, a Form 5 for one transaction occurring in 1998,
and a Form 5 for one transaction occurring in 1997. Mr. Morrell reported the
above transactions and one other transaction on a Form 5 filed late on March 23,
2000. Theodore Orlando failed to timely file three Form 4s reporting six
transactions occurring in 1999, a Form 5 reporting two transactions in 1997, and
a Form 5 reporting one transaction in 1998. Mr. Orlando reported the above
transactions and two other transactions on a Form 5 filed late on March 23,
2000. Paul Pershes failed to timely file three Form 4s reporting eleven
transactions, and one Form 5 reporting one transaction occurring in 1997. Mr.
Pershes reported the above transactions and two other transactions on a Form 5
filed late on March 30, 2000. Dana Pusateri failed to timely file two Form 4s
reporting two transactions occurring in 1999, and a Form 5 reporting one
transaction occurring in 1998. Mr. Pusateri reported the above transactions and
one other transaction on a Form 5 filed late on March 23, 2000.

ITEM 10. EXECUTIVE COMPENSATION

The following table displays information concerning compensation paid or
accrued for the fiscal year ended December 31, 1997, 1998 and 1999, for the
benefit of our named executive officers. Each of the named executive officers
received other personal benefits in amounts less than 10% of their total annual
salary and bonus.

24
<PAGE>
SUMMARY OF COMPENSATION TABLE

<TABLE>
<CAPTION>
ANNUAL COMPENSATION LONG TERM COMPENSATION AWARDS
-------------------------------------- ------------------------------------------------
NAME & PRINCIPAL RESTRICTED STOCK SECURITIES UNDERLYING ALL OTHER
POSITION YEAR SALARY ($) BONUS($) AWARD(S) OPTIONS/WARRANTS COMPENSATION ($)
- -------------------------- --------- ----------------- ---------- -------------------- --------------------------- ----------------
<S> <C> <C> <C>
Michael F. Morrell 1999 $225,526 1,000,000
1998 $160,000 600,000
1997 $173,461 1,500,000

Paul C. Pershes 1999 $198,077 400,000
1998 $153,462 500,000
1997 $104,808 1,437,000

Linda Moore 1999 $117,884 350,000
1998 85,577 150,000
1997 95,000 75,000

Arthur Kobrin 1999 $111,634 100,000
1998 85,346 150,000
1997 42,000 100,000

Louis Capece 1999 $150,115 100,000
</TABLE>

Mr. Morrell was granted in January 1997, 1,175,000 ten-year options to
purchase common stock at $.50 per share, all of which have vested, under an
employee agreement. Mr. Morrell exercised 1,000,000 of those options in February
1998. In November 1997, the board of directors granted Mr. Morrell 300,000
ten-year options to purchase common stock at $1.25 a share, all of which have
been exercised. In February 1998, the board of directors granted Mr. Morrell
600,000 ten-year options to purchase common stock $1.25 a share, 400,000 of
which have been exercised. In September 1999, the board of directors granted Mr.
Morrell, 1,000,000 five-year options to purchase common stock at $1.00 per
share, all of which have been exercised.

Mr. Pershes was granted in January 1997, 1,175,000 ten-year options to
purchase common stock at $.50 per share, all of which have vested, under an
employee agreement. Mr. Pershes exercised 1,000,000 of those options in February
1998. In November 1997, the board of directors granted Mr. Pershes 250,000
ten-year options to purchase common stock at $1.25 a share, all of which have
been exercised. In February 1998, the board of directors granted Mr. Pershes
500,000 ten-year options to purchase common stock at $1.25 a share, 333,334 of
which have been exercised. In September 1999, the board of directors granted Mr.
Pershes, 400,000 five-year options to purchase common stock at $1.00 per share,
200,000 of which have been exercised.

Mr. Kobrin was granted in January 1997, 100,000 ten-year options to
purchase common stock at $1.48 per share, all of which have vested, under an
employee agreement. Mr. Kobrin exercised all 100,000 of those options in
September 1999. In February 1998, the board of directors granted Mr. Kobrin
150,000 ten-year options to purchase common stock at $1.25 a share, 125,000 of
which have been exercised. In September 1999, the board of directors granted Mr.
Kobrin, 100,000 five-year options to purchase common stock at $1.00 per share,
50,000 of which have been exercised.

25
<PAGE>
Linda Moore was granted 100,000 ten-year options to purchase common stock
at $.50 per share, all of which have vested, under an employee agreement entered
into. Ms. Moore has exercised all 100,000 of those options. In February 1998,
the board of directors granted Ms. Moore 150,000 ten-year options to purchase
common stock at $1.25 a share, 125,000 of which have been exercised. In
September 1999, the board of directors granted to Ms. Moore 350,000 five-year
options to purchase common stock at $1.00 per share, 175,000 of which have been
exercised.

Louis R. Capece, Jr. was granted in September 1999 five-year options to
purchase 100,000 shares of common stock at $1.00 per share of which 50,000 have
vested, and the remainder vest annually over a two year period.

EMPLOYMENT AGREEMENTS

AGREEMENT WITH MICHAEL MORRELL

In January 1997, we entered into an employment agreement with Michael
Morrell ending January 2002, which currently provides for an annual salary of
$250,000, grants 1,175,000 stock options at $.50 per share, and provides for the
payment of normal business expenses. Mr. Morrell's base salary may be increased
at the discretion of the board of directors. The employment agreement provides
for a bonus to be determined by the board of directors.

AGREEMENT WITH PAUL PERSHES

In January 1997, we entered into an employment agreement with Paul C.
Pershes expiring in January 2002, which currently provides for an annual salary
of $200,000. Mr. Pershes' base salary may be increased at the discretion of the
board of directors. The employment agreement provides for a bonus as well as the
issuance of options to purchase common stock, as determined by the board of
directors.

AGREEMENT WITH ARTHUR KOBRIN

In June 1997, we entered into an employment agreement with Arthur Kobrin,
expiring in June 2001, which currently provides for an annual salary of
$125,000. Mr. Kobrin's base salary may be increased at the discretion of the
board of directors. The employment agreement provides for a bonus as well as the
issuance of options to purchase common stock, as determined by the board of
directors.

AGREEMENT WITH LINDA MOORE

In November 1996, we entered into an employment agreement with Linda Moore
expiring in November 2001, which currently provides for an annual salary of
$150,000. Ms. Moore's base salary may be increased at the discretion of the
board of directors. The employment agreement provides for a bonus as well as the
issuance of options to purchase common stock, as determined by the board of
directors.

AGREEMENT WITH JOHN HAINES

In July 1999, we entered into an employment agreement with John Haines as
senior vice president in charge of technology and effective September 1, 1999 as
president of our subsidiary, CyberCare, Inc. The agreement expires in July 2002
and provides for an annual base salary of $175,000. The employment agreement
provides for a bonus as well as the issuance of options to purchase common
stock, as determined by the board of directors. The employment agreement
includes a covenant not to compete during the term of the agreement and for a
two-year period thereafter in the United States. Mr. Haines' base salary may be
increased at the discretion of the board of directors.

26
<PAGE>
AGREEMENT WITH LOUIS R. CAPECE, JR.

In March 1999, we entered into an employment agreement with Louis R.
Capece, Jr. as President and Chief Executive Officer of Air Response. The
agreement expires in March 2004 and provides for an annual base salary of
$175,000. The employment agreement provides for issuance of nonqualified stock
options, based on specified future events as defined in the employment
agreement. The employment agreement includes a covenant not to compete during
the term of the agreement and for a two-year period thereafter in the United
States. Mr. Capece's base salary may be increased at the discretion of the board
of directors.

The following tables show, as to the named executive officers, certain
information concerning stock options:

OPTION GRANTS DURING 1999

PERCENT OF
NUMBER OF TOTAL OPTIONS EXERCISE
SECURITIES GRANTED TO OR BASE
UNDERLYING EMPLOYEES PRICE EXPIRATION
NAME OPTIONS IN FISCAL YEAR ($/SH) DATE
---- ---------- -------------- -------- ----------
Michael F. Morrell 1,000,000 19.5% $1.00 9/7/04

Paul C. Pershes 400,000 7.8% $1.00 9/7/04

Linda Moore 350,000 6.8% $1.00 9/7/04

Louis R. Capece, Jr. 100,000 1.9% $1.00 9/7/04

Arthur Kobrin 100,000 1.9% $1.00 9/7/04

With respect to the options granted to the officers described immediately above:

AGGREGATED OPTIONS EXERCISES IN LAST FISCAL YEAR AND FY-END OPTION VALUES

<TABLE>
<CAPTION>
SHARES ACQUIRED ON VALUE NUMBER OF SECURITIES UNDERLYING VALUE OF UNEXERCISED IN THE MONEY
NAME EXERCISE REALIZED UNEXERCISED OPTIONS AT FY-END (#) OPTIONS
---- ------------------ -------- --------------------------------- ---------------------------------
<S> <C> <C> <C> <C> <C> <C>
EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
Michael Morrell 2,097,000 420,000 175,000 $3,455,850 $1,422,750
Paul C. Pershes 808,334 - 341,666 200,000 $2,823,578 $1,626,000
Linda Moore 2,097,000 - 420,000 175,000 $3,455,850 $1,422,750
Louis R. Capece, Jr. - - 50,000 50,000 $406,500 $406,500
Arthur Kobrin 200,000 - 35,000 50,000 $289,550 $406,500
</TABLE>

Mr. Morrell and Ms. Moore are married and under the rules of beneficial
ownership we have combined their securities.

27
<PAGE>
The table above includes both warrants and options. The value of
unexercised in-the-money warrants and options was computed based on the
differences between the closing market price of $9.13, as of Friday, December
31, 1999, and the aggregate exercise prices of the warrants and options.

COMPENSATION OF DIRECTORS

We have paid no direct or indirect remuneration, nor is any currently
payable by us, to the directors in their capacity as directors other than the
granting of stock options and $1,000 for each meeting attended in person. We
expect that, during the next twelve months, we will not pay any direct or
indirect remuneration to any directors of ours in their capacity as directors
other than in the form of stock option grants or the reimbursement of expenses
of attending directors' or committee meetings.

The following table shows all compensation paid to outside directors:

<TABLE>
<CAPTION>
CASH COMPENSATION SECURITY GRANTS
----------------------------- --------------------------------------
CONSULTING NUMBER OF
MEETING FEE / OTHER NUMBER OF SECURITIES UNDERLYING
NAME ANNUAL RETAINER FEE ($) FEES ($) FEES ($) SHARES (#) OPTIONS/SARS (#)
---- ----------------------------- -------- -------- ---------- ----------------
<S> <C> <C> <C> <C> <C>
Terry Lazar - 3,000 - - 275,000

Glen Barber - 3,000 - - 125,000

Theodore J. Orlando - 1,000 - - 275,000
</TABLE>

The board of directors had 13 meetings during 1999, of which 11 were
telephonic meetings. Outside directors receive $1,000 for each meeting they
attend, up to a maximum of $5,000. Both inside and outside directors may be
awarded stock options for other meetings and work performed.

LIMITATION OF DIRECTORS' LIABILITY

Our amended and restated articles of incorporation eliminate, to the
fullest extent permitted by Florida law, the personal liability of our directors
for monetary damages for breaches of fiduciary duty. However, our amended and
restated articles of incorporation do not provide for the elimination or
limitation of the personal liability of a director for acts or omissions that
involve intentional misconduct, fraud, or a knowing violation of the law, or
unlawful corporate distributions. These provisions will limit the remedies
available to the stockholder who is dissatisfied with a decision of the board of
directors protected by these provisions, and the stockholder's only remedy may
be to bring a suit to prevent the action of the board. This remedy may not be
effective in many situations because stockholders are often unaware of a
transaction or an event before the board's action. In these cases, our
stockholders and our Company could be injured by a board's decision and have no
effective remedy.

ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The table below displays, as of March 24, 2000, the beneficial ownership
of our common stock by

o our directors;

o our named executive officers;

o the holders of five percent or more of our common stock; and

o our directors and officers as a group.

28
<PAGE>
<TABLE>
<CAPTION>
NUMBER OF SHARES OF PERCENTAGE
NAME COMMON STOCK BENEFICIALLY OWNED OF CLASS
- ---- ------------------------------- -------------
<S> <C> <C>
Michael F. Morrell 3,834,290 6.6%

Paul C. Pershes 2,282,200 4.0%

Linda Moore 3,834,290 6.6%

Arthur Kobrin 342,882 less than 1%

John Haines 2,150,666 3.7%

Theodore J. Orlando 362,500 less than 1%

Terry Lazar 532,500 1%

Glen Barber 362,500 less than 1%

Dana Pusateri 1,248,533 2.1%

Louis R. Capece, Jr. 3,143,334 5.5%

Robert Coleman 62,500 less than 1%

All Directors and Officers as a
group (11 persons) 14,321,905 24.0%
</TABLE>
The business address of each of the beneficial owners is 1903 S. Congress
Ave., Suite 400, Boynton Beach, Florida 33426.

We have determined beneficial ownership following the rules of the SEC. In
computing the number of shares beneficially owned by a person and the percentage
ownership of that person, we have included the shares of common stock subject to
options and warrants held by that person that are currently exercisable or will
become exercisable within 60 days after March 30, 2000, but we have not included
those shares for purposes of computing the percentage ownership of any other
person. We have assumed, unless indicated below that the persons and entities
named in the table have sole voting and investment power for all shares
beneficially owned subject to applicable community property laws.

The shares of common stock beneficially owned by Mr. Morrell and Ms. Moore
include 1,000,000 shares received in 1998 and 1,750,000 shares in 1999 upon the
exercise of an option at aggregate exercise prices of $2,450,000. Upon the
exercise of that option, Mr. Morrell issued to Cyber-Care promissory note for
the purchase price, at the following terms: (1) repayment of principal with
interest at the Federal applicable rate, (2) pledge of the shares as collateral
security for repayment of the loan, and (3) repayment of the principal and
interest upon the earlier to occur of the sale of the shares or 2004. In
February 2000, Mr. Morrell repaid $500,000 of the note by tendering 25,000
common shares to CyberCare in a cashless exercise.

The shares of common stock beneficially owned by Mr. Pershes include
1,000,000 shares received in 1998 and 808,334 shares in 1999 upon the exercise
of options to purchase shares of common stock at aggregate exercise prices of

29
<PAGE>
$1,466,668. Upon the exercise of that option, Mr. Pershes issued Cyber-Care a
promissory note in payment for the shares, which note contained the following
terms: (1) repayment of principal with interest at the Federal applicable rate,
(2) pledge of the shares as collateral security for repayment of the loan, and
(3) repayment of the principal and interest upon the earlier to occur of the
sale of the shares or 2004. In February 2000, Mr. Pershes repaid $500,000 of the
note by tendering 25,000 common shares to CyberCare in a cashless exercise.

The shares of common stock beneficially owned by Mr. Kobrin include 75,000
shares received in 1998 and 200,000 shares in 1999 upon the exercise of options
to purchase shares of common stock of aggregate exercise prices of $354,250.
Upon the exercise of that option, Mr. Kobrin issued Cyber-Care a promissory note
in payment for the shares, which note contained the following terms: (1)
repayment of principal with interest at the Federal applicable rate, (2) pledge
of the shares as collateral security for repayment of the loan, and (3)
repayment of the principal and interest upon the earlier to occur of the sale of
the shares or 2004. In February 2000, Mr. Kobrin repaid $93,750 of the note by
tendering 4,688 common shares to Cyber-Care in a cashless exercise.

The beneficial ownership of the persons in the table above includes the
following options or warrants to purchase shares of our common stock that are
currently exercisable or may be exercised by the person within 60 days of March
30, 2000:

SECURITIES EXERCISABLE WITHIN 60 DAYS OF MARCH 30, 2000

OPTIONS/
WARRANTS
---------
Michael Morrell ......................... 420,000
Paul Pershes............................. 341,666
Linda Moore ............................. 420,000
Arthur Kobrin............................ 35,000
John Haines ............................. 50,000
Ted Orlando ............................. 362,500
Terry Lazar ............................. 362,500
Glen Barber ............................. 362,500
Dana Pusateri ........................... 275,000
Louis Capece ............................ 50,000
Robert Coleman .......................... 62,500

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Except as discussed in Item 11 and $79,937 loans made to Louis Capece Jr.,
there were no transactions, or series of transactions, during fiscal 1998 or
1999, nor are there any currently proposed transactions, or series of
transactions, to which we are a party, in which the amount exceeds $60,000, and
in which to our knowledge any director, executive officer, nominee, five percent
or greater shareholder, or any member of the immediate family of any of the
foregoing persons, have or will have any direct or indirect material interest.

ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K

(a) The following exhibits are to be filed as part of this Form 10-KSB:

EXHIBIT NO. IDENTIFICATION OF EXHIBIT
- ----------- -------------------------
2.1 Stock Exchange Agreement between Medical Industries of
America, Inc. and CyberCare, Inc. Previously filed as an
exhibit to a Form 8-K dated July 15, 1999.

30
<PAGE>
EXHIBIT NO. IDENTIFICATION OF EXHIBIT
- ----------- -------------------------
3.1 Amended and Restated Articles of Incorporation. Incorporated
by reference from the exhibit with the same reference number
in our Registration Statement.

3.2 Amended and Restated Bylaws. Incorporated by reference from
the exhibit with the same reference number in our
Registration Statement.

3.3 Articles of Amendment to the Articles of Incorporation.
Previously filed as an exhibit, with the same reference
number, to our Registration Statement on Form S-3, which was
filed on February 11, 2000.

4.1 Investment Agreement. Previously filed as an exhibit, with the
same reference number, to our Registration Statement on Form
SB-2 filed on November 30, 1999.

4.2 Registration Rights Agreement. Previously filed as an exhibit,
with the same reference number, to our Registration
Statement on Form SB-2 filed on November 30, 1999.

4.3 Escrow Agreement and Instructions. Previously filed as an
exhibit, with the same reference number, to our Registration
Statement on Form SB-2 filed on November 30, 1999.

4.4 Warrant to Purchase Common Stock of Medical Industries of
America, Inc. ("N" Shares). Previously filed as an exhibit,
with the same reference number, to our Registration
Statement on Form SB-2 filed on November 30, 1999.

4.5 Warrant to Purchase Common Stock of Medical Industries of
America, Inc. ("425,000" Shares) . Previously filed as an
exhibit, with the same reference number, to our Registration
Statement on Form SB-2 filed on November 30, 1999.

4.6 Letter to Corporate Stock Transfer. Previously filed as an
exhibit, with the same reference number, to our Registration
Statement on Form SB-2 filed on November 30, 1999.

4.7 Agreement. Previously filed as an exhibit, with the same
reference number, to our Registration Statement on Form SB-2
filed on November 30, 1999.

4.8 Acknowledgement. Previously filed as an exhibit, with the same
reference number, to our Registration Statement on Form SB-2
filed on November 30, 1999.

10.1 Form of Indemnification Agreement between the Registrant and
each of its directors and certain executive officers.
Incorporated by reference from the exhibit with the same
reference number in our Registration Statement.

10.2 Form of agreement between the Company and its client
hospitals. Incorporated by reference from the exhibit with
the same reference number in our Registration Statement.

10.15 Employment Agreement - Michael Morrell. Previously filed as an
exhibit, with the same reference number, to our Annual
Report on Form 10-KSB for the year ended December 31, 1996.

10.16 Employment Agreement - Arthur Kobrin. Previously filed as an
exhibit, with the same reference number, to our Annual
Report on Form 10-KSB for the year ended December 31, 1997.

10.17 Employment Agreement - Linda Moore. Employment Agreement..
Previously filed as an exhibit, with the same reference
number, to our Annual Report on Form 10-KSB for the year
ended December 31, 1997.

31
<PAGE>
EXHIBIT NO. IDENTIFICATION OF EXHIBIT
- ----------- -------------------------
10.18 Share Exchange Agreement between MIOA Acquisition Company I,
Inc. and Global Air Rescue, Inc. Previously filed as an
exhibit, with the same reference number, to a Form 8-K dated
January 6, 1998.

10.19 Share Exchange Agreement between MIOA Acquisition Company I,
Inc. and Global Air Charter, Inc. Previously filed as an
exhibit, with the same reference number, to a Form 8-K dated
January 6, 1998.

10.20 Share Exchange Agreement between MIOA Acquisition Company I,
Inc. and Clearwater Jet Center, Inc. Previously filed as an
exhibit, with the same reference number, to a Form 8-K dated
January 6, 1998.

10.22 Employment Agreement by and between Medical Industries of
America, Inc. and John E. Haines. Previously filed as an
exhibit to a Form 8-K dated July 15, 1999.

10.23 Amendment No. 1 to the Employment Agreement by and between
Medical Industries of America, Inc. and John E. Haines.
Previously filed as an exhibit to a Form 8-K dated July 15,
1999.

10.24 Agreement of Purchase and Sale by and between HELP
Innovations, Inc., HELP Innovations Acquisition Corp., Inc.,
Cyber-Care, Inc. and Linda L. Roman and Innovative Health of
Kansas, Inc. Previously filed as an exhibit, with the same
reference number, to our Registration Statement on Form S-3,
which was filed on February 11, 2000.

10.25 Agreement and Plan of Merger by and among Medical Industries
of America, Inc., MIOA Acquisition Company IV, Inc., Your
Good Health Network, Inc., and Dr. David Vastola, Dana
Pusateri, Dr. Martin Santiago, Juan Cocuy, Irma Espinoza,
Randy Davis, Elaine Callendrillo, Lydia Torregrosa-Greber,
Richard Hoffman and Eric Conn. Previously filed as an
exhibit, with the same reference number, to our Registration
Statement on Form S-3, which was filed on February 11, 2000.

16 Acknowledgement letter from Grant Thornton LLP regarding its
resignation as the Company's independent public accountants
(1).

21.1 List of Subsidiaries. Filed herewith.

(b) There have been no reports filed on Form 8-K other than
the item referenced in Exhibit 16 above.

(1) Form 8-K filed with the Commission on May 26, 1999.

32
<PAGE>
SIGNATURES

In accordance with the Section 13 or 15(d) of the Exchange Act, the
registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

DATED: April 3, 2000 CYBER-CARE, INC.

By: //s// PAUL C. PERSHES
Paul C. Pershes
President and Director

In accordance with the Exchange Act, this report has been signed below by
the following persons on behalf of the registrant and in the capacities and on
the dates indicated.

SIGNATURE TITLE DATE
--------- ----- ----

//s// MICHAEL F. MORRELL Chairman, Director, April 3, 2000
Michael F. Morrell Chief Executive Officer

//s// ARTHUR KOBRIN Senior Vice President April 3, 2000
Arthur Kobrin of Financial Operations

//s// LINDA MOORE Senior Vice President and April 3, 2000
Linda Moore Secretary

//s// JOHN HAINES Senior Vice President and April 3, 2000
John Haines Director

//s// LOUIS R. CAPECE, JR. Director April 3, 2000
Louis R. Capece, Jr.

//s// GLEN BARBER Director April 3, 2000
Glen Barber

//s// TED ORLANDO Director April 3, 2000
Ted Orlando

//s// DANA PUSATERI Director April 3, 2000
Dana Pusateri

//s// TERRY LAZAR Director April 3, 2000
Terry Lazar

//s// ROBERT COLEMAN Director April 3, 2000
Robert Coleman

33
<PAGE>
CYBER-CARE, INC.
Medical Industries of America, Inc.
Index to Consolidated Financial Statements

PAGE
----
Reports of Independent Certified Public Accountants.................... F-2-F-2A

Consolidated Balance Sheets............................................ F-3

Consolidated Statements of Operations.................................. F-5

Consolidated Statements of Shareholders' Equity........................ F-6

Consolidated Statements of Cash Flows.................................. F-7

Notes to Consolidated Financial Statements............................. F-9

F-1
<PAGE>
REPORT OF INDEPENDENT
CERTIFIED PUBLIC ACCOUNTANTS

Board of Directors
Cyber-Care, Inc.

We have audited the accompanying consolidated balance sheet of Cyber-Care, Inc.
and subsidiaries as of December 31, 1999, and the related consolidated
statements of operations, shareholders' equity, and cash flows for the year then
ended. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audit.

We conducted our audit in accordance with auditing standards generally accepted
in the United States. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free
of material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement
presentation. We believe that our audit provides a reasonable basis for our
opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of Cyber-Care, Inc.
and subsidiaries at December 31, 1999, and the consolidated results of their
operations and their cash flows for the year then ended, in conformity with
accounting priniciples generally accepted in the United States.

Ernst & Young LLP
West Palm Beach, FL
February 24, 2000

F-2
<PAGE>
[GRANT THORNTON LETTERHEAD]

REPORT OF INDEPENDENT
CERTIFIED PUBLIC ACCOUNTANTS

Board of Directors
Cyber-Care, Inc.

We have audited the accompanying consolidated balance sheet of Cyber-Care, Inc.
F/K/A Medical Industries of America, Inc. and subsidiaries as of December 31,
1998, and the related consolidated statements of operations, shareholders'
equity, and cash flows for the year then ended. These financial statements are
the responsibility of the Company's management. Our responsibility is to express
an opinion on these financial statements based on our audit.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of Cyber-Care, Inc.
F/K/A Medical Industries of America, Inc. and subsidiaries as of December 31,
1998 and the consolidated results of their operations and their consolidated
cash flows for the year then ended, in conformity with accounting principles
generally accepted in the United States.

/s/ Grant Thornton

Weston, Florida
March 26, 1999

F-2A
<PAGE>
CYBER-CARE, INC.
CONSOLIDATED BALANCE SHEETS
DECEMBER 31,

ASSETS

1999 1998
------------ ------------
CURRENT ASSETS
Cash and cash equivalents .................... $ 11,758,607 $ 698,574
Accounts receivable - net .................... 5,850,513 3,307,196
Proceeds due from escrow agent ............... 5,142,895 --
Inventories of medical supplies .............. 327,380 97,219
Prepaid expenses and other current assets .... 1,186,911 677,285
------------ ------------

Total current assets ..................... 24,266,306 4,780,274
------------ ------------
PROPERTY AND EQUIPMENT
Aircraft and related equipment ............... 21,194,642 9,297,415
Medical equipment ............................ 774,328 456,748
Furniture, office and transportation equipment 1,424,884 858,428
Property and improvements .................... 407,812 258,642
------------ ------------
23,801,666 10,871,233

Less accumulated depreciation and amortization (2,927,793) (1,241,136)
------------ ------------

Net property and equipment ............... 20,873,873 9,630,097
------------ ------------
OTHER ASSETS
Investment in equity securities .............. 655,580 2,863,840
Goodwill, net of accumulated amortization of
$501,370 and $179,171, at December 31, 1999
and 1998, respectively ...................... 7,463,791 8,338,972
Deferred costs ............................... 6,456,579 432,685
Licenses, net of accumulated amortization of
$451,221 and $58,824, at December 31, 1999
and 1998, respectively ...................... 13,493,610 941,176
Other assets ................................. 648,776 332,470
------------ ------------

Total other assets ....................... 28,718,336 12,909,143
------------ ------------

TOTAL ASSETS ......................... $ 73,858,515 $ 27,319,514
============ ============

SEE ACCOMPANYING NOTES

F-3
<PAGE>
CYBER-CARE, INC.
CONSOLIDATED BALANCE SHEETS
DECEMBER 31,

LIABILITIES AND SHAREHOLDERS' EQUITY
<TABLE>
<CAPTION>
1999 1998
------------ ------------
<S> <C> <C>
CURRENT LIABILITIES

Accounts payable ......................................... $ 2,995,720 $ 2,080,663
Accrued expenses ......................................... 1,464,586 967,528
Lines of credit .......................................... 3,781,592 1,789,827
Current maturities of notes payable and
long-term debt ......................................... 2,030,215 1,827,835
Current maturities of capital lease obligations .......... 27,558 39,497
Current maturities of subordinated debentures ............ 367,500 125,000
Net liabilities of discontinued operations ............... 773,524 268,984
------------ ------------

Total current liabilities .......................... 11,440,695 7,099,334

Subordinated debentures .................................. -- 367,500
Notes payable and long-term debt, less current
maturities ............................................ 11,584,010 5,956,267
Convertible subordinated debentures, net of
discounts of $4,617,416 and $0 for the years
ended December 31, 1999 and 1998, respectively ......... 15,827,584 3,000,000
Capital lease obligations, less current
maturities ............................................ 55,080 19,948

Other long-term liabilities .............................. 155,074 379,639
------------ ------------
Total liabilities .................................. 39,062,443 16,822,688
------------ ------------

COMMITMENTS
SHAREHOLDERS' EQUITY

Preferred stock, authorized 20,000,000 shares;
19,800,000 shares available for issuance
Series B convertible shares, issued, $10 stated value, 0
and 27,250 issued and outstanding at December 31,
1999 and 1998, respectively ............................ -- 215,913
Common stock, .0025 par value, authorized
200,000,000: issued and outstanding 48,654,660
and 23,352,924 shares at December 31, 1999 and
1998, respectively ..................................... 121,636 58,381
Capital in excess of par ................................. 79,549,448 38,915,876
Notes receivable from officers ........................... (4,655,168) (1,050,000)
Accumulated other comprehensive income ................... (1,768,049) --
Accumulated deficit ...................................... (38,451,795) (27,643,344)
------------ ------------
Total shareholders' equity ......................... 34,796,072 10,496,826
------------ ------------
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY .... 73,858,515 27,319,514
============ ============
</TABLE>
SEE ACCOMPANYING NOTES

F-4
<PAGE>
CYBER-CARE, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

<TABLE>
<CAPTION>
YEAR ENDED DECEMBER 31
-----------------------------
1999 1998
------------ ------------
<S> <C> <C>
REVENUE
Revenue from operations ......................... $ 37,899,705 $ 13,430,969
Gain on sale of subsidiary ...................... 1,255,959 --
------------ ------------
Total Revenue ................................... 39,155,664 13,430,969

COST AND EXPENSES
Cost of services ................................ 20,981,078 5,553,257
General and administrative expenses ............. 13,739,200 8,337,762
Research and development costs .................. 348,782 --
Depreciation and amortization ................... 2,596,329 1,304,864
------------ ------------
Total cost and expenses ..................... 37,665,389 15,195,883
------------ ------------
Operating income (loss) ........................... 1,490,275 (1,764,914)
------------ ------------
OTHER INCOME (EXPENSES)
Interest income ................................. 97,675 282,803
Gain on sale of investment ...................... 169,868 --
Interest expense ................................ (2,728,195) (1,040,570)
Interest - beneficial conversion feature ........ (8,572,247) (1,109,163)
Other expenses .................................. -- (300,951)
------------ ------------

Total other income (expenses) ............. (11,032,899) (2,167,881)
------------ ------------

Loss from continuing operations before
extraordinary item .............................. (9,542,624) (3,932,795)

Discontinued operations

Loss from operations ............................ (575,827) (2,107,416)
Estimated loss on disposal ...................... (690,000) (1,510,308)
------------ ------------
Loss before extraordinary item .................... (10,808,451) (7,550,519)
Extraordinary item - gain from retirement of
debt ........................................... -- 169,566
------------ ------------

Net loss .......................................... $(10,808,451) $ (7,380,953)
============ ============

(Loss) income per common share - Basic and diluted:

Loss from continuing operations before
extraordinary item ............................ $ (.29) $ (.19)
Discontinued operations ......................... (.04) (.17)
Extraordinary item .............................. -- .01
------------ ------------
Net loss ........................................ $ (.33) $ (.35)
============ ============
Weighted average common shares outstanding ...... 32,882,376 20,709,334
============ ============
</TABLE>

SEE ACCOMPANYING NOTES

F-5
<PAGE>
CYBER-CARE, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
FOR THE YEARS ENDED DECEMBER 31, 1999 AND 1998

<TABLE>
<CAPTION>
PREFERRED STOCK COMMON STOCK
----------------------------- -----------------------------

CAPITAL IN
SHARES AMOUNT SHARES AMOUNT EXCESS OF PAR
------------ ------------ ------------ ------------ ------------
<S> <C> <C> <C> <C> <C>
Balance, January 1, 1998 ....... 1,492,600 $ 2,699,500 14,565,712 $ 36,413 $ 30,297,862

Common stock issued for
acquisitions .................. -- -- 5,971,208 14,929 5,710,357
Common shares returned ......... -- -- (175,500) (439) 439
Exercise of stock options ...... -- -- 2,100,000 5,250 1,044,750
Interest - beneficial conversion
feature ....................... -- -- -- -- 1,109,163
Settlement of lawsuits ......... -- -- 466,504 1,166 522,493
Reversal of acquisition
agreements ..................... (1,289,000) (959,500) 425,000 1,062 230,812
Adjustment for equity
investment .................... (5,659) (56,587) -- -- --
Return of preferred shares ..... (176,350) (1,467,500) -- -- --
Net loss ....................... -- -- -- -- --
------------ ------------ ------------ ------------ ------------
Balance - December 31, 1998 .... 21,591 215,913 23,352,924 58,381 38,915,876

Repurchase of preferred stock .. (21,591) (215,913) -- -- --
Common stock and warrants issued
for acquisitions .............. -- -- 12,583,293 31,458 14,398,545
Conversion of debentures ....... -- -- 7,904,668 19,762 5,227,853
Common stock issued for services
and interest expense .......... -- -- 640,777 1,602 558,022
Common stock received as
consideration for sale of
subsidiary .................... -- -- (1,598,842) (3,997) (2,799,676)
Common stock issued on exercise
of stock options and warrants . -- -- 5,738,045 14,345 5,681,973
Interest - beneficial conversion
feature ....................... -- -- -- -- 8,572,247
Fair market value of detachable
warrants issued with
subordinated debentures ....... -- -- -- -- 9,034,062
Common stock issued for payment
on long-term debt ............. -- -- 118,223 294 70,641
Common shares issued in
settlement of lawsuit ......... 296,000 742 151,170
Common stock issued under
employee stock purchase plan .. -- -- 6,239 16 27,768
Unrealized loss on investment
in equity securities........... -- -- -- -- --
NET LOSS ....................... -- -- -- -- --
Comprehensive loss ............. -- -- -- -- --
Common shares returned upon
separation agreement .......... -- -- (386,667) (967) (289,033)
------------ ------------ ------------ ------------ ------------
Balance - December 31, 1999 .... -- -- 48,654,660 $ 121,636 $ 79,549,448
============ ============ ============ ============ ============
<CAPTION>
NOTES ACCUMULATED
RECEIVABLE OTHER TOTAL
FROM COMPREHENSIVE ACCUMULATED SHAREHOLDERS'
OFFICERS INCOME DEFICIT EQUITY
------------ ------------ ------------ ------------
<S> <C> <C> <C> <C>
Balance, January 1, 1998 ....... -- $ -- $(20,262,391) $ 12,771,384

Common stock issued for
acqusitions ................... -- -- -- 5,725,286
Common shares returned ......... -- -- -- --
Exercise of stock options ...... (1,050,000) -- -- --
Interest - beneficial conversion
feature ....................... -- -- -- 1,109,163
Settlement of lawsuits ......... -- -- -- 523,659
Reversal of acquisition
agreements ..................... -- -- -- (727,626)
Adjustment for equity
investment .................... -- -- -- (56,587)
Return of preferred shares ..... -- (1,467,500)
Net loss ....................... -- -- (7,380,953) (7,380,953)
------------ ------------ ------------ ------------
Balance - December 31, 1998 .... (1,050,000) -- (27,643,344) 10,496,826

Repurchase of preferred stock .. -- -- -- (215,913)
Common stock and warrants issued
for acquisitions .............. -- -- -- 14,430,003
Conversion of debentures ....... -- -- -- 5,247,615
Common stock issued for services
and interest expense .......... -- -- -- 559,624
Common stock received as
consideration for sale of
subsidiary .................... -- -- -- (2,803,673)
Common stock issued on exercise
of stock options and warrants . (3,605,168) -- -- 2,091,150
Interest - beneficial conversion
feature ....................... -- -- -- 8,572,247
Fair market value of detachable
warrants issued with
subordinated debentures ....... -- -- -- 9,034,062
Common stock issued for payment
on long-term debt ............. -- -- -- 70,935
Common shares issued in
settlement of lawsuit ......... -- -- -- 151,912
Common stock issued under
employee stock purchase plan .. -- -- -- 27,784
Unrealized loss on investment
in equity securities........... -- (1,768,049) -- (1,768,049)
Net loss ....................... -- -- (10,808,451) (10,808,451)
------------
Comprehensive loss ............. -- -- -- (12,576,500)
Common shares returned upon
separation agreement .......... -- -- -- (290,000)
------------ ------------ ------------ ------------
Balance - December 31, 1999 .... $ (4,655,168) $ (1,768,049) $(38,451,795) $ 34,796,072
============ ============ ============ ============
</TABLE>

F-6
<PAGE>
CYBER-CARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 1999 AND 1998

<TABLE>
<CAPTION>
YEAR ENDED DECEMBER 31
-----------------------------
1999 1998
------------ ------------
Operating activities
<S> <C> <C>
Net loss .................................................................. $(10,808,451) $ (7,380,953)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation ............................................................ 1,848,379 972,954
Amortization ............................................................ 747,950 331,910
Provision for doubtful accounts ......................................... 77,139 172,500
Common stock issued in exchange for services and interest expense ....... 559,624 --
Equity in net income of investee ........................................ -- (80,685)
Interest - beneficial conversion feature ................................ 8,572,247 1,109,163
Write-off of goodwill ................................................... -- 844,167
Forgiveness of debt ..................................................... -- (30,000)
Loss on disposition of property and equipment ........................... -- 234,862
Gain on sale of investment .............................................. (169,868) --
Gain on sale of subsidiary .............................................. (1,255,959) --
Estimated loss on disposal of discontinued operations ................... 690,000 1,510,308
Changes in operating assets and liabilities:
Accounts receivable .................................................... (1,067,929) (690,837)
Inventories of medical supplies ........................................ (160,161) (15,908)
Prepaid expenses and other current assets .............................. 27,949 (161,753)
Accounts payable ....................................................... (2,254,858) 188,037
Accrued expenses ....................................................... (1,538,661) (697,866)
------------ ------------
Net cash used in operating activities ..................................... (4,732,599) (3,694,101)

INVESTING ACTIVITIES
Purchases of property and equipment ....................................... (2,487,570) (1,315,011)
Proceeds from sale of equity securities ................................... 60,833 --
Cash (paid for) received from acquisitions, net ........................... (18,733) 81,737
Purchase of goodwill ...................................................... -- (223,769)
Cash paid for deferred costs .............................................. (2,964,493) --
Proceeds from sale of subsidiary .......................................... 352,000 --
Change in other assets .................................................... (254,561) (250,127)
Change in net assets of discontinued operations ........................... (185,460) 418,243
------------ ------------
Net cash used in investing activities ..................................... (5,497,984) (1,288,927)

FINANCING ACTIVITIES
Proceeds from exercise of warrants ........................................ 2,091,150 --
Common stock issued under employee stock purchase plan .................... 27,784 --
Payments on capital lease obligations ..................................... (29,454) (169,542)
Repayments on notes payable ............................................... (1,846,775) (1,198,278)
Proceeds from notes payable ............................................... 382,517 2,999,479
Advances under lines of credit ............................................ 23,946,431 --
Repayments on lines of credit ............................................. (22,004,166) --
Proceeds from sale of convertible debentures .............................. 18,723,129 3,367,500
Payments on convertible debentures ........................................ -- (275,000)
------------ ------------
Net cash provided by financing activities ................................. 21,290,616 4,724,159

Net change in cash and cash equivalents ................................... 11,060,033 (258,869)
Cash and cash equivalents at beginning of period .......................... 698,574 957,446
------------ ------------
Cash and cash equivalents at end of period ................................ $ 11,758,607 $ 698,577
============ ============

SUPPLEMENTAL DISCLOSURE OF NON CASH INVESTING AND FINANCING ACTIVITIES
Cash paid for interest .................................................... $ 2,135,915 $ 1,006,568
============ ============
Equipment acquired through capital leases ................................. $ 52,647 $ --
============ ============
</TABLE>

SEE NOTES TO CONSOLIDATED FINANCIAL STATEMENTS.

F-7
<PAGE>
CYBER-CARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 1999 AND 1998

Supplemental disclosure on non-cash investing and financing activities:

<TABLE>
<CAPTION>
1999 1998
------------ ------------
<S> <C> <C>
Common stock issued for services and interest expense $ 559,624 --
============ ============

Common stock received as consideration for sale of
subsidiary or reversal of acquisition ............... $ 2,803,673 $ 727,626
============ ============

Common stock issued for payment of long-term debt.... $ 70,935 --
============ ============

Common shares returned upon separation agreement..... $ 290,000 --
============ ============

Common shares issued in settlement of lawsuit........ $ 151,912 $ 523,659
============ ============

Warrants issued for in exchange for debt issuance
services............................................. 3,517,696 --
============ ============

</TABLE>

The following is a summary of the assets acquired, liabilities assumed, the
value of the common stock issued and warrants issued and cash paid for, or
received from, companies acquired:

1999 1998
------------ ------------
Assets acquired:
Accounts receivable ....................... $ 1,552,527 $ 1,467,077
Property and equipment .................... 10,551,938 714,941
Goodwill .................................. 1,233,062 7,551,110
Licenses .................................. 12,987,374 --
Other ..................................... 334,180 203,813
------------ ------------
Fair value of assets acquired ......... 26,659,081 9,936,941
------------ ------------
Liabilities assumed:
Accounts payable .......................... 3,169,916 1,213,657
Accrued expenses .......................... 1,398,861 531,701
Long-term debt ............................ 7,641,568 2,384,560
------------ ------------
Fair value of liabilities assumed .... 12,210,345 4,129,918
------------ ------------
Common stock and warrants issued for
acquisitions .............................. 14,430,003 5,725,286
------------ ------------
Cash (paid for) received from acquirees .... $ (18,733) $ 81,737
============ ============

F-8
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

ORGANIZATION

Cyber-Care, Inc. F/K/A Medical Industries of America, Inc. ("Cyber-Care" or the
"Company") was incorporated in the State of Florida on September 29, 1989 and
commenced operations on February 27, 1990.

The Company is a technology assisted health management company with four
business segments; disease management technology, physical, occupational and
speech therapy centers, pharmacy services and an air ambulance transport
service.

At the Company's annual meeting held in August 1999, the shareholders approved
an increase in the number of authorized common shares to 200,000,000 from
100,000,000 and approved the change in the Corporation's name to Cyber-Care,
Inc.

PRINCIPLES OF CONSOLIDATION

The consolidated financial statements for 1999 include the activity of the
Company and its wholly-owned subsidiaries, CyberCare, Inc. ("CyberCare"),
Global Air Charter, Inc., Global Air Rescue, Inc., and Clearwater Jet Center,
Inc. (Collectively "Global"), Pharmacy Care Specialists, Inc. ("PCS"), Ivanhoe
Medical Systems, Inc. ("Ivanhoe"), Air Response North, Inc. ("AIR"), E-Care
Solutions, Inc. ("E-Care"), Help Innovations Acquisition Corp, Inc. ("Help"),
Southeast Medical Centers, Inc. ("Southeast"), Carolina Rehab, Inc.
("Carolina"), Valley Pain Centers, Inc. ("Valley"), Your Good Health Network,
Inc. ("YGHN"), and Heart Labs of America, Inc. ("HLOA").

All inter-company accounts and transactions have been eliminated in
consolidation.

CASH AND CASH EQUIVALENTS

Cash and cash equivalents include investments in highly-liquid debt instruments
with original maturities of three months or less.

USE OF ESTIMATES

The preparation of financial statements in conformity with general accepted
accounting principles requires management to make estimates and assumptions that
affect the amounts reported in the financial statements and accompanying notes.
Actual results could differ from those estimates.

F-9
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

INVENTORIES OF MEDICAL SUPPLIES

Inventories of medical supplies are stated at the lower of cost or market,
determined on the first-in, first-out method.

PROPERTY AND EQUIPMENT

Property and equipment are stated at cost. Depreciation is provided using the
straight-line method over the estimated useful lives of the assets. Amortization
of assets held under capital lease agreements is included in depreciation and
amortization expense and is provided using the straight-line method over the
shorter of the lease term or estimated useful lives of the assets. The estimated
lives of the Company's property and equipment range from 5-20 years.

Property and equipment at December 31, 1999 and 1998 consisted of the following:

1999 1998
----------- -----------
Property and equipment owned ................... $23,698,841 $10,830,459
Medical equipment held under capital leases .... 102,825 40,774
----------- -----------
$23,801,666 $10,871,233
=========== ===========

Accumulated amortization of medical equipment held under capital leases was
$14,145 and $1,728 at December 31, 1999 and 1998, respectively.

F-10
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

GOODWILL AND LICENSES

Goodwill is recorded at cost and is amortized using the straight-line method
over periods ranging from 20 - 25 years.

Licenses, which primarily consist of medical technology and other licenses, are
recorded at cost and are amortized using the straight line method.
Technology-related licenses are amortized over 10 years while commercial
aircraft licenses are being amortized over 20 years.

LONG-LIVED ASSETS

Long-lived assets are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount may not be recoverable.
Recoverability of assets is measured by comparison of the carrying amount of the
asset to net future cash flows expected to be generated from the asset. During
1998, the Company wrote off approximately $2,355,000 of goodwill as a result of
discontinuing certain of its operations (See note 14). No impairments were
recognized in 1999.

INVESTMENT IN EQUITY SECURITIES

In 1998, the Company had a 21% investment in Westmark Group Holdings, Inc.
("Westmark"), and accordingly, accounted for the investment under the equity
method of accounting in 1998. Under the equity method the Company's share of the
net income (loss) of Westmark is recognized as income (loss) in the Company's
statement of operations.

During 1999, the Company exchanged a portion of its investment in Westmark in
return for $215,913 of the Company's preferred stock which was held by Westmark,
as well as the repurchase by Westmark of $666,666 of Westmark common stock held
by the Company (See Note 4) thus reducing the Company's investment in Westmark
to 6%. Subsequent to this exchange, the Company began accounting for its
investment in Westmark as an available-for-sale security. Accordingly, the
Company has adjusted the investment to its fair market value as of December 31,
1999 and reflected an unrealized loss on marketable securities of $1,768,049
which is included in shareholder's equity.

REVENUE

Revenue is recognized at the time the service is provided. Medicare and Medicaid
reimbursements ("third-party") are recognized based on allowable charges. The
difference between the Company's established billing rates and contracted or
anticipated reimbursement rates is recorded as a contractual allowance and
offset against net revenue. These revenues are subject to audit and retroactive
adjustment by the respective third-party fiscal intermediaries. In the opinion
of management, retroactive adjustments, if any, would not be material to the
financial statements of the Company.

F-11
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

ADVERTISING

The Company's advertising expense consists primarily of print media, yellow book
advertising and promotional material. Advertising costs are expensed as incurred
and, for 1999 and 1998, were $557,422 and $95,672, respectively.

Stock-Based Compensation

The Company accounts for employee stock options using the intrinsic value method
as prescribed by Accounting Principles Board Opinion No. 25 ACCOUNTING FOR STOCK
ISSUED TO EMPLOYEES. The Company follows the disclosure provisions of Statement
of Financial Accounting Standard ("SFAS") No. 123, ACCOUNTING FOR STOCK BASED
COMPENSATION and for valuing common stock equivalents issued to nonemployees.

RECENT ACCOUNTING PRONOUNCEMENTS

In June 1998, the Financial Accounting Standards Board issued SFAS No. 133,
ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES. SFAS No. 133 is
effective for fiscal years beginning after January 1, 2001. SFAS No. 133
requires that all derivative instruments be recorded on the balance sheet at
their fair value. Changes in the fair value of derivatives are recorded each
period in current earnings or other comprehensive income, depending on whether a
derivative is designed as part of a hedge transaction and, if it is, the type of
hedge transaction. The Company does not expect that the adoption of SFAS No. 133
will have a material impact on its financial statements because the Company does
not currently hold any derivative instruments.

COMPREHENSIVE INCOME

The Company has adopted SFAS No. 130, REPORTING COMPREHENSIVE INCOME, which
requires that all items that are recognized under accounting standards as
components of comprehensive income be reported in a financial statement that is
displayed with the same prominence as other financial statements. The items of
other comprehensive income that are typically required to be displayed are
foreign currency items, minimum pension liability adjustments, and unrealized
gains and losses on certain investments in debt and equity securities.

ESTIMATED FAIR VALUE OF FINANCIAL INSTRUMENTS

The following methods and assumptions were used to estimate the fair value of
each class of financial instruments for which it is practicable to estimate that
value:

F-12
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Cash, accounts receivable, accounts payable: The carrying amounts approximate
fair value because of the short maturity of those instruments.

Notes payable and long-term debt: The carrying amounts approximate fair value
due to the length of the maturities and the interest rates not being
significantly different from the current market rates available to the Company.

Convertible subordinated debentures: The fair value of the Company's convertible
subordinated debentures was approximately $28,700,000 and $3,500,000 at December
31, 1999 and 1998, respectively. Fair value of the convertible subordinated
debentures was determined by comparing the fair value of similar issues of debt
by other companies as well as taking into account the interest rate of the debt
and the value of the Company's common stock at December 31, 1999 and
1998.

RECLASSIFICATIONS

Certain reclassifications have been made in the 1998 financial statements to
conform with the 1999 presentation.

2. ACQUISITIONS AND DISPOSITIONS

Effective April 1, 1998, the Company acquired 100% of the outstanding stock of
PCS, an institutional pharmacy, in exchange for 680,000 shares of the Company's
common stock valued at $1.56 per share and a $90,000 note payable to the selling
shareholders. The excess of the purchase price over the fair market value of the
net assets acquired of approximately $1,036,593 was recognized as goodwill.

Effective April 1, 1998, the Company acquired 81% of the outstanding stock of
Ivanhoe in exchange for 637,875 shares of the Company's common stock valued at
$1.56 per share. Effective September 1, 1998, the Company acquired the remaining
19% of the outstanding stock in exchange for $660,000 in cash and notes. The
excess of the purchase price over the fair market value of the net assets
acquired of $1,969,170 was recognized as goodwill.

Effective September 1, 1998, the Company acquired 100% of the outstanding stock
of Valley, in exchange for 1,320,000 shares of the Company's common stock valued
at $1.00 per share, or $1,320,000. The excess of the purchase price over the
fair market value of the net assets acquired of $1,529,327 was recognized as
goodwill.

F-13
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

2. ACQUISITIONS AND DISPOSITIONS (continued)

Effective October 15, 1998, the Company acquired 100% of the outstanding stock
of YGHN in exchange for 3,333,333 shares of the Company's common stock valued
at $.75 per share, or $2,500,000. The excess of the purchase price over the fair
market value of the net assets acquired of $2,830,646 was recognized as
goodwill. In 1999, one of the former shareholders of YGHN terminated his
agreement with the Company and as part of his termination, he returned 386,667
shares of the Company's common stock which reduced goodwill by $290,000.

Effective March 1, 1999, the Company acquired 100% of the outstanding common
stock of Air in exchange for 3,866,667 shares of common stock valued at $.75 per
share plus $2,900,000 of additional consideration which is contingent upon Air
achieving certain agreed upon pre-tax profit levels. The contingent
consideration is payable in convertible debentures over thirty-nine months, but
is conditional upon Air earning $3,900,000 in pretax profits over the same
period. If the earnings targets are not achieved the principal face value of the
convertible debentures will be reduced. If the annual profits in any formula
period (as defined in the acquisition agreement between the Company and Air) are
less than $600,000, the debentures will be reduced by $966,667. The debentures
will bear interest at 9.5% and will be payable as follows: $200,000 on the last
day of the 27th month following the closing and the remainder on the last day of
the 42nd month following closing. The debentures may be converted at any time to
the Company's common shares at the rate of $1.00 per share. The debentures are
secured by the assets of Air. The excess of the purchase price over the fair
market value of the net assets acquired of $1,015,136 was recognized as
goodwill.

On May 3, 1999, Valley was sold to two former officers of the Company for the
return of 1,598,842 shares of the Company's common stock with a market value of
$2,803,673 ($1.75 a share), cash and other consideration of $352,000, and the
repayment of approximately $300,000 of liabilities owed by Valley, which
resulted in a gain of $1,255,959. The Company retired the 1,598,842 shares of
the Company's common stock which were received from this transaction.

During 1999, the Company, through YGHN, issued 57,630 common shares valued at
$1.09 per share, plus cash of $12,500 for the purchase of certain assets and the
assumption of certain liabilities of the Institute for Wellness, Inc. This
transaction resulted in goodwill of $21,763.

Effective August 1, 1999, the Company acquired 100% of the outstanding common
stock of Carolina Rehab, Inc. in exchange for consideration which is contingent
upon Carolina Rehab achieving certain agreed upon levels of pre-tax profit. The
Company anticipates such additional consideration will be between $3,000,000 -
$6,000,000 and will be paid in shares of the Company's common stock based upon
the market price of the common stock at the time the consideration is earned.
The excess of the liabilities assumed over the fair market value of the net
assets acquired was $34,062 which was recognized as goodwill.

F-14
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

2. ACQUISITIONS AND DISPOSITIONS (continued)

Effective August 1, 1999, the Company acquired 100% of the outstanding common
stock of Southeast Medical Centers, Inc. in exchange for consideration which is
contingent upon Southeast Medical Centers achieving certain agreed upon pre-tax
profit levels. The Company anticipates such additional consideration will be
between $1,000,000 - $1,500,000 and will be paid in shares of the Company's
common stock based upon the market price of the common stock at the time the
consideration is earned. The excess of the liabilities assumed over the fair
market value of the net assets acquired was approximately $162,101 which was
recognized as goodwill.

Effective September 1, 1999, the Company acquired 100% of the outstanding common
stock of Cybercare, Inc. ("Cybercare") in exchange for 7,324,996 shares of
common stock valued at $1.12 per share and options to purchase 934,997 shares of
the Company's common stock with a fair value of $553,836. The former
shareholders of Cybercare, Inc. have been given registration rights which
provide that if the fair market value of the Company's common stock at the
effective date of the registration of these shares is less than $1.50, enough
additional shares will be issued to ensure that those shareholders have received
at least $1.50 per share.

The Company received an exclusive worldwide license by acquiring CyberCare to
manufacture, sell and use the "Electronic Housecall System" throughout the
world. In consideration for granting the license, the Company has agreed to pay
to the former shareholders of CyberCare $2,100,000 over a three year period for
additional research and development and a 4% royalty on all sales of Electronic
Housecall System. The two corporations with which the Company obtained the
licensing agreement were also shareholders of Cybercare and received 1,313,238
shares of the Company's common stock.

Effective November 15, 1999, the Company, acquired certain assets of HELP
Innovations, Inc ("HELP"). In exchange for these assets, the company issued
1,334,000 shares of common stock to HELP valued at $2,709,354, or $2.03 per
share.

Each of the above acquisitions was accounted for under the purchase method of
accounting. Accordingly, the results of operations of each have been included in
the Company's consolidated statements of operations from their respective dates
of acquisition.

The following unaudited pro forma summary presents the consolidated results of
operations as if the Company's acquisitions and disposition had occurred on
January 1, 1998, after giving effect to certain adjustments, primarily
amortization of goodwill. The pro forma financial information does not purport
to be indicative of the results of operations that would have occurred had the
transactions taken place at the beginning of the periods presented or of future
results of operations.

F-15
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

2. ACQUISITIONS AND DISPOSITION (continued)

1999 1998
------------- -------------
Total Revenue .............................. $ 40,499,691 $ 28,541,047
============= =============
Loss before extraordinary item ............. $ (12,541,521) $ (8,494,954)
============= =============
Net loss ................................... $ (12,541,521) $ (8,664,520)
============= =============
Loss per common share - basic and diluted... $ (.37) $ (.42)
============= =============

3. ACCOUNTS RECEIVABLE

Accounts receivable as of December 31, 1999 and 1998 consists of the following:

1999 1998
---------- ----------
Accounts receivable ........................ $7,140,407 $4,462,365
Allowance for doubtful accounts ............ 1,289,894 1,155,169
---------- ----------
$5,850,513 $3,307,196
========== ==========

4. SALE OF INVESTMENT IN EQUITY SECURITIES

During 1998, the Company entered into an agreement with Westmark which allows
the Company to require Westmark to repurchase Westmark common shares which are
held by the Company if Westmark's earnings per share do not meet certain
criteria. Westmark did not meet this requirement, therefore the Company required
Westmark to repurchase $666,666 of Westmark's common stock held by the Company
at a price of $5.73 per share. The consideration received by the Company was
$394,166 in cash, of which $60,837 has been received with the balance due when
Westmark's 1999 Form 10-KSB is filed, and return of all of the Company's
outstanding preferred stock held by Westmark valued at $272,500. The Company
generated a $169,868 gain from this sale.

5. CUSTOMERS AND CREDIT CONCENTRATION

F-16
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

5. CUSTOMERS AND CREDIT CONCENTRATION (continued)

The Company has no one customer which individually accounted for greater than
10% of revenue from operations. During 1999 and 1998, the Company derived its
revenue primarily throughout the United States.

Revenue is generated from each of the Company's segments in 1999 as follows:

Air ambulance transport services ............................ 55.6%
Physical, occupational and speech
therapy .................................................. 24.6%
Pharmacy services ........................................... 12.4%
Disease management technology ............................... 4.1%
Corporate ................................................... 3.3%
-----

100%
=====

6. NOTES PAYABLE AND LONG-TERM DEBT

Notes payable and long-term debt as of December 31, 1999 and 1998 consisted of
the following:

1999 1998
----------- -----------
Notes payable, payable in monthly
installments of $203,543 including
interest at rates of prime plus 1.25%
to prime plus 1.5% (9.75% - 10% at
December 31, 1999), maturing through
November 2003; collateralized by
aircraft and related equipment. The
notes are also personally guaranteed by
the chief executive officer of the
air ambulance subsidiary. .................... $12,711,332 $ 6,329,509

Note payable, payable in monthly
installments of $12,352, interest
at 8.5%, maturing May 2003. This note
was paid off in 1999. ........................ -- 317,751

Note payable, principal and interest
of prime plus 1%, adjusted annually
(8.75% at December 31, 1998), due in
monthly installments through October
1999, uncollateralized and guaranteed
by a shareholder. This note was paid
off in 1999. ................................. -- 41,667

Note payable, interest only at 10%,
collaterialized by common stock. This note
was ammended and assigned to a private
corporation in 1999 and is payable upon demand 600,000 600,000

F-17
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

6. NOTES PAYABLE AND LONG-TERM DEBT (continued)

1999 1998
----------- -----------
Notes payable, payable in monthly
installments of $4,400, with interest
varying from 7% to 14%, maturing
through March 14, 2002,
collateralized by various equipment .......... 171,473 184,394

Other .......................................... 131,420 310,781
----------- -----------
13,614,225 7,784,102
Less current maturities ........................ 2,030,215 1,827,835
----------- -----------
$11,584,010 $ 5,956,267
=========== ===========

Maturities of notes payable and long-term debt as of December 31, 1999 are as
follows:

YEAR ENDING DECEMBER 31 AMOUNT
----------------------- -----------
2000 $ 2,030,215
2001 1,749,996
2002 3,763,078
2003 6,065,568
2004 5,368
-----------
$13,614,225
===========

During 1998, the Company settled a note in the amount of $300,000 plus accrued
interest of $139,566 by paying $270,000. The Company recorded an extraordinary
gain on the retirement of this debt in the amount of $169,566.

7. LINES OF CREDIT

In July 1998, the Company entered into a $1,500,000 line of credit agreement
with a financing company. The line bears interest at prime plus 2.65% (11.15% at
December 31, 1999), and expires in July 2000. During 1999, the financing company
increased the amount of borrowings available under this agreement to $3,500,000.
The line is secured by the accounts receivables of certain of the Company's
subsidiaries. As of December 31, 1999, the Company had outstanding borrowing of
$2,930,841 under this agreement.

In 1998, the Company entered into a $250,000 line of credit agreement with a
bank. This line of credit bears interest at 8%, matures in January 2000, and was
collateralized by certain furniture, fixtures and equipment of the Company. As
of December 31, 1999, the Company had $133,326 outstanding under this agreement,
all of which was repaid in January 2000.

In 1998, the Company entered into a $1,500,000 line of credit agreement with a
financial institution. This line of credit bears interest at prime plus 2%
(10.50% at December 31, 1999), matures October 13, 2001, and is collateralized
by the Company's accounts receivable. As of December 31, 1999, the Company had
outstanding borrowing under this agreement of $717,425.

F-18
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

8. CONVERTIBLE SUBORDINATED DEBENTURES

In 1997, the Company issued $400,000 of 12% convertible subordinated debentures
(the "Debentures"). The Debentures had original maturity dates between February
1999 and September 1999 with interest payable monthly. The Debentures were
repaid in 1999.

In June 1998, the Company issued $367,500 of 10% subordinated debentures due
June 2000. As of December 31, 1999, the entire $367,500 is outstanding.

On July 31, 1998, the Company issued $3,000,000 of 6% convertible A debentures,
which required semi-annual payments of interest and mature on July 29, 2001. The
holders of the 6% convertible A debentures received warrants to purchase 300,000
shares of the Company's common stock at an exercise price of $2.50 per share.
The fair value of these warrants was $102,000 or $.34 per warrant. The
underwriter received warrants to purchase 60,000 shares of the Company's common
stock at an exercise price of $2.00. The fair value of these warrants was
$37,000 or $.45 per share. The fair value of the warrants was recorded as a
discount to the 6% convertible A debentures which was accreted through interest
expense over the life of the debentures. The convertible A debentures were
issued through J.W. Genesis Financial Services Capital Markets and were issued
to accredited investors. The total offering price was $3,000,000, less the
underwriter's commission of $180,000.

The convertible A debentures were convertible into the Company's common stock
based on the lower of $2.00 per share or 82.5% of the market value, with a
minimum conversion price of $1.00. The convertible A debentures were converted
into 2,918,001 shares of common stock during 1999.

During 1999, the Company, pursuant to a private placement, sold $2,000,000 of
12% convertible debentures (the "12% debentures") together with 2,000,000
detachable warrants. The warrants may be exercised at any time through April
2002 at $.50 per share. The debentures were due through April 2002 with
interest. The debentures are convertible at any time into common stock at a
conversion price of $.50 per share. The market price of the Company's common
stock was between $.656 and $1.125 per share on the dates the 12% debentures
were issued with the majority of the debentures issued when the Company's common
stock was approximately $.656 per share. As a result, the Company recorded a
beneficial conversion of $699,830 which was immediately recognized as additional
interest expense. The proceeds were used for general corporate purposes. As
of September 30, 1999, the 12% debentures were converted into 4,000,000 common
shares of the Company.

During 1999, the Company, pursuant to a private placement, sold $7,345,000 of
10% subordinated convertible debentures (the "10% Debentures").

F-19
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

8. CONVERTIBLE SUBORDINATED DEBENTURES (continued)

The 10% debentures, less issuance costs of $499,743, included 3,672,500
detachable warrants to purchase shares of the Company's common stock. The
Warrants are exercisable for a period of five years from date of grant at prices
ranging from $1.11 - $1.50 per share. The proceeds allocated to the warrants was
$2,761,720 and was recorded as a discount to the 10% Debentures. The unamortized
balance of such discount was $2,157,347 at December 31, 1999. The discount is
being accreted through interest expense over the life of the underlying
debentures. The 10% debentures are convertible at exercise prices of $1.00 -
$1.50. per share and are immediately convertible upon issuance. The conversion
price was less than the market value per share of the Company's common stock on
the dates the 10% debentures were issued. As a result, the Company recorded a
beneficial conversion feature of $4,583,280 which was immediately recognized as
additional interest expense. During 1999, $1,225,000 of the 10% convertible
debentures were converted into 986,667 shares of common stock. The 10%
convertible debentures had an outstanding balance of $6,120,000 at December 31,
1999.

In December 1999, the Company, pursuant to a qualified institutional buyer
private placement ("QUIB"), sold $14,325,000 of 10% subordinated convertible
debentures (the "December 1999 debentures"). The December 1999 debentures less
issuance costs of $1,947,874 included 1,705,356 detachable warrants which are
exercisable at $4.20 per share at any time within six years from the date of
grant. The December 1999 Debentures are convertible at $3.50 per share and are
immediately convertible upon issuance. The conversion price was less than the
market value per share of the Company's common stock on the dates the December
1999 Debentures were issued. As a result, the Company recorded a beneficial
conversion feature of $2,478,225 which was immediately recognized as additional
interest expense. The fair value of the warrants was $3,034,347, or $1.78 per
share, and was recorded as a discount to the December 1999 debentures. The
discount is being accreted through interest expense over the life of the
underlying debentures. The unamortized balance of such discount was $2,460,069
at December 31, 1999. The entire balance of these debentures was outstanding as
of December 31, 1999.

9. LEASES

The Company leases two mobile labs under operating leases which expire July 31,
2002. The Company leases various office space under non-cancelable operating
leases which expire through April 2001.

Future minimum payments under non-cancelable operating leases consisted of the
following as of December 31, 1999:

YEAR ENDING DECEMBER 31, OPERATING LEASES
------------------------ ----------------
2000 $ 1,716,465
2001 1,153,058
2002 1,014,373
2003 838,643
2004 639,427
2005 212,095
----------------
Total lease payments $ 5,574,061
================

F-20
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

9. LEASES (continued)

Rent expense for the years ended December 31, 1999 and 1998 totaled $1,250,716
and $1,587,987, respectively.

The Company has acquired equipment under capital lease obligations. Future
minimum lease payments under capital lease obligations at December 31, 1999 are
as follows:

2000 $111,909
2001 59,062
2002 35,404
2003 21,606
2004 6,687
-------
TOTAL 234,668
Less: Imputed interest 152,030
-------
Total minimum lease payments, net 82,638
Current maturities of capital
lease obligations 27,558
-------
Capital lease obligations, less
current maturities $55,080
=======

10. INCOME TAXES

The Company had no current or deferred income tax expense or benefit in either
1999 or 1998, as the Company experienced losses in both years and a valuation
allowance has been provided for the resulting deferred tax assets as noted
below.

Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amount of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. Significant components of
the Company's net deferred income taxes are as follows:

YEARS ENDED DECEMBER 31
----------------------------
1999 1998
---------- ----------
Deferred tax assets:
Operating loss carryforwards ............... $5,820,200 $5,651,600
Allowance accounts ......................... 1,036,200 817,400
Prepaid insurance .......................... 35,100 25,500
Other ...................................... 10,800 6,800
---------- ----------
Total gross deferred tax assets .......... 6,902,300 6,501,500
Less valuation allowance ................ (6,526,800) (6,471,900)
----------
Net deferred tax assets ................. 375,500 29,600

Deferred tax liabilities:
Depreciation and amortization .............. 375,500 29,600
---------- ----------
Total deferred tax liabilities ............. 375,500 29,600
---------- ----------

Total net deferred taxes ................... $ 0 $ 0
========== ==========

F-21
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

SFAS 109 requires a valuation allowance to reduce the deferred tax assets
reported if, based on the weight of the evidence, it is more likely than not
that some portion or all of the deferred tax assets will not be realized. After
consideration of all the evidence, both positive and negative, management has
determined that a $6,526,800 valuation allowance at December 31, 1999 is
necessary to reduce the deferred tax assets to the amount that will more likely
than not be realized. The change in the valuation allowance for the current year
is an increase of $54,900. At December 31, 1999, the Company has available net
operating loss carryforwards of $15,467,000 which expire beginning in 2008.

The Company may have experienced a change in ownership as defined by Internal
Revenue Code section 382. The Company has not completed a study to determine
what effects the change of ownership rules may have on the Company's net
operating loss carryforwards. Internal Revenue Code section 382 could place an
annual limitation on the Company's ability to realize the benefit of its net
operating loss carryforwards. As such, a portion of the Company's net operating
loss carryforwards may never be realized.

The reconciliation of income tax computed at the U.S. federal statutory rate to
income tax expense is as follows:

YEARS ENDED DECEMBER 31
-------------------------
1999 1998
---------- ----------

Tax at U.S. statutory rate ....................... (34.00)% (34.00)%

State taxes, net of federal benefit .............. (3.64) (3.63)

Non-deductible items ............................. 37.12 18.97

Change in valuation allowance .................... 0.52 18.66
---------- ----------
0.00% 0.00%
========== ==========

11. STOCK OPTIONS

As of December 31, 1999, the Company had the following stock option plans:

1996 Stock Option An aggregate of 5,000,000 shares of common stock
Plan for Officers & are reserved for issuance. As of December 31,
Directors 1999, 0 shares remained available for issuance
under this plan.

1996 Employee Stock An aggregate of 1,000,000 shares of common stock
Option Plan are reserved for issuance. As of December 31,
1999, 0 shares remained available for issuance
under this plan.

1999 Directors and An aggregate of 4,000,000 shares of common stock
Executive Officers are reserved for issuance. As of December 31,
Stock Option Plan 1999, 375,000 shares remained available for
issuance under this plan.

1999 Incentive Stock An aggregate of 2,000,000 shares of common stock
Option Plan are reserved for issuance. As of December 31,
1999, 1,820,500 shares remained available for
issuance under this plan.

The Compensation Committee of the Company's Board of Directors, administers and
interprets the plans and is authorized to grant options to eligible
participants.

F-22
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

11. STOCK OPTIONS (continued)

The exercise price of all options granted by the Company equals the market price
at the date of grant. Accordingly, no compensation expense has been recognized.

Had compensation cost for the options issued to employees under the plans been
determined based on the fair value of the options at the grant dates consistent
with the provisions of SFAS 123, the Company's net loss per common share would
have been changed to the pro forma amounts indicated below.

1999 1998
-------------- --------------
Pro forma net loss ........................ $ (13,137,604) $ (8,832,412)
============== ==============
Proforma income (loss) per common share -
Basic and diluted:
Loss from continuing operations before
extraordinary item .................... $ (.36) $ (.27)
Discontinued operations ................. (.04) (.17)
Extraordinary item ...................... -- .01
-------------- --------------
Net loss ................................ $ (.40) $ (.43)
============== ==============

The above pro forma disclosures may not be representative of the effects on
reported net operations for future years as options vest over several years and
the Company may continue to grant options to employees.

The fair value of each option grant is estimated on the date of grant using the
Black Scholes option-pricing model with the following weighted-average
assumptions,

1999 1998
---- ----
Dividend yield 0.00% 0.00%
Expected volatility .914 - 1.05 1.69
Risk-free interest rate 5% 5.7% - 6.6%
Expected life 3-10 years 3-10 years

A summary of stock options issued by the Company together with changes during
the periods indicated, is as follows:

DECEMBER 31
---------------------------------------------------
1999 1998
------------------------- ------------------------
WEIGHTED - WEIGHTED -
AVERAGE AVERAGE
EXERCISE EXERCISE
SHARES PRICE SHARES PRICE
----------- ------------ ---------- ------------
Outstanding at
beginning of year 3,752,000 $ 1.28 4,652,000 $ .87
Granted 5,134,498 1.42 2,100,000 1.26
Exercised (3,135,333) 1.15 (2,100,000) .50
Forfeited (100,000) 1.25 (900,000) 1.23
----------- ------------ ---------- ------------

F-23
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

11. STOCK OPTIONS (continued)

Outstanding at end of
year 5,651,165 $ 1.46 3,752,000 $ 1.28
=========== ============ ========== ============

Options exercisable at
end of year 2,315,836 2,080,333
=========== ==========

Weighted=average fair
value of options
granted during the
year $ 1.03 $ 1.23
=========== ==========

The following information applies to options outstanding at December 31, 1999:

OPTIONS OUTSTANDING OPTIONS EXERCISABLE
---------------------------------- --------------------
WEIGHTED-
AVERAGE WEIGHTED - WEIGHTED -
REMAINING AVERAGE AVERAGE
RANGE OF CONTRACTUAL EXERCISE EXERCISE
EXERCISE PRICES SHARES LIFE PRICE SHARES PRICE
- --------------- --------- ------------- ----------- --------- -----------
$ 0 - $.50 480,000 7.03 $ .50 480,000 $ .50
.75 - .91 608,333 7.62 .76 373,333 .76
1.00 - 1.81 3,683,333 6.92 1.24 1,158,336 1.20
2.06 - 2.25 575,000 4.80 2.18 254,167 2.20
5.00 - 8.00 294,499 7.96 5.29 40,000 7.10
$ 20.00 10,000 1.44 $ 20.00 10,000 $20.00
--------- ---------
5,651,165 2,315,836
========= =========

At the Company's annual meeting, the shareholders approved the 1999 Employee
Stock Purchase Plan (the "Stock Purchase Plan"). The Stock Purchase Plan allows
employees to purchase shares of the Company's common stock in an amount not to
exceed up to 15% of their annual compensation. The employee can enter the plan
on either January 1 or July 1 of each year. Shares acquired through the Stock
Purchase Plan are purchased at the lower of 85% of the fair market value of the
Company's common stock at either the first or last day of the period. As of
December 31, 1999, certain employees of the Company purchased 6,239 shares of
the Company's common stock valued at $27,784 under this plan.

12. WARRANTS

During the year ended December 31, 1999, the Company issued warrants to acquire
common stock of the Company. The warrants were issued as part of the private
placements issued in 1999. Each warrant represents the right to purchase one
share of common stock for prices ranging from $.50 to $4.20 per warrant.
Warrants unexercised as of December 31, 1999 are as follows:

F-24
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

12. WARRANTS (continued)

NUMBER OF WARRANTS EXERCISE PRICE EXPIRATION DATES
------------------ -------------- ----------------
310,000 $.50 February 2002-April 2002
500,000 .62 September 2003
574,998 .75 January 2001-October 2005
70,000 1.10 December 2002
75,000 1.15 September 2004
4,192,394 1.25 September 2000 - 2004
25,000 1.33 September 2004
100,000 1.47 December 2002
786,750 1.50 December 2000-September 2004
150,000 1.75 December 2002
425,000 1.93 May 2001
14,750 2.00 November 2002
400,000 2.50 July 2001
581,785 3.50 December 2004
1,616,074 $ 4.20 March 2005

The weighted average grant date fair value of warrants granted during 1999 was
$1.59 and was computed using the Black-Scholes option pricing model and the same
assumptions disclosed in Note 11.

A summary of the activity of the Company's warrants is as follows;

1999 1998
----------- -----------

Outstanding at beginning of year. 2,650,931 1,180,000

Granted ......................... 10,073,532 1,470,931

Exercised ....................... (2,602,712) --

Forfeited........................ (300,000) --

----------- -----------
Outstanding at end of year....... 9,821,751 2,650,931
=========== ===========

13. EARNINGS PER SHARE

The Company adopted SFAS No. 128, EARNINGS PER SHARE, effective January 1, 1998.
In accordance with the requirements of SFAS No. 128, basic earnings per share is
computed by dividing net income by the weighted average number of shares
outstanding and diluted earnings per share reflects the dilutive effects of
stock options (as calculated utilizing the treasure stock method) and the
equivalent common shares of outstanding convertible preferred stock. Shares of
common stock which are issuable upon the exercise of options and warrants, or
upon conversion of debentures, have been excluded from the 1998 and 1999 per
share calculations because their effect would have been anti-dilutive.

14. DISCONTINUED OPERATIONS

During the third quarter of 1999, the Company reviewed the operations of the
mobile cardiac cath business. Due to government regulation changes, the Company
determined that it was in the best interest of its shareholders to sell this
subsidiary.

The results of this subsidiary have been classified as discontinued operations
in the accompanying financial statements. Net liabilities of the discontinued
operations at December 31, 1999 consist primarily of trade payables and accrued
expenses. The loss

F-25
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

14. DISCONTINUED OPERATIONS (continued)

on disposal of the discontinued operations at December 31, 1999 was $690,000 and
includes a provision for anticipated future expenses related to the discontinued
operations. The loss on disposal of the discontinued operations at December 31,
1998 is $1,510,308, consisting of a loss on disposal of $1,108,231 and a
provision of $402,077 for anticipated future expenses related to these
discontinued operations.

During the third quarter of 1998, the Company reviewed the operations of two of
its subsidiaries, FPII and PRN. The Company determined that it was in the best
interest of its shareholders to sell FPII and discontinue the operations of PRN.

The results of these subsidiaries have been classified as discontinued
operations in the accompanying financial statements. The Company ceased the
operations of FPII as of December 31, 1998. PRN ceased operations effective
September 30, 1998.

Revenue from discontinued operations was $694,176 and $2,660,141 for the years
ended December 31, 1999 and 1998 respectively, and is included as part of the
loss from discontinued operations in the accompanying statements of operations.

15. ISSUANCES AND REPURCHASES OF COMMON STOCK AND PREFERRED STOCK

On September 15, 1999, the Company sold 150,000 shares of its common stock at
$1.00 per share in exchange for notes totaling $150,000. The notes bear interest
at 10% and are payable as of the effective date the shares are registered. The
note is collateralized by the restricted common shares purchased and has been
offset against shareholders equity as of December 31, 1999.

In 1999, the Company issued 640,777 shares of the Company's common stock as
payment for services rendered and accrued interest on outstanding debt. The
value of the shares was $559,624 when issued which was based on the Company's
market price on that date.

F-26
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

15. ISSUANCES AND REPURCHASES OF COMMON STOCK AND PREFERRED STOCK

In 1999, the Company issued 296,000 shares of the Company's common stock in
repayment of notes payble totaling $151,912 and settlement of prior year lawsuit
previously expensed in 1998.

In 1999, the Company issued 118,223 shares of the Company's common stock to
officers and employees in repayment of loans valued at $.60 per share or
$70,935.

During 1999, certain officers exercised stock options to acquire 3,135,334
common shares of the Company at exercise prices ranging from $1.00 - $1.48. The
Company received a note from each officer which bears interest at the Federal
Applicable rate. The notes are collateralized by the common shares.

During 1999, the Company issued 2,602,712 shares of the Company's common stock
for warrants exercised at exercise prices ranging from $.50 to $2.50 per share.

On February 25, 2000, certain officers repaid a portion of their notes due the
Company under the Company's cashless exercise policy. The notes were repaid by
reducing the number of shares due the officers by 58,750 common shares. Total
shares issued after repayment of the note was 2,141,250 common shares.

The Company has 20,000,000 shares of preferred stock authorized, and 19,800,000
shares of preferred stock available for issuance which may be used in one or
more series as determined by the board of directors of the Company. In partial
payment on the sale of shares of Westmark common stock, the Company received
$272,500 or 200,000 shares of previously issued preferred stock held by
Westmark. Upon receipt, such shares were retired.

16. BUSINESS SEGMENT INFORMATION

The Company adopted SFS No. 131, "Disclosures About Segments of An Enterprise
and Related Information," in 1998 which changed the way the Company reports
information about its operating segments. With the September 1, 1999 acquisition
of Cyber-Care, the Company reorganized itself into four main business units:
International Air Ambulance, Physical and Occupational Rehabilitation, Pharmacy
Services, and Technology Assisted

F-27
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

16. BUSINESS SEGMENT INFORMATION (continued)

Disease Management. Certain reclassifications have been made to the 1998
information in order to conform to the 1999 presentation.

INTERNATIONAL AIR AMBULANCE TRANSPORT offers national and international
fixed-wing air ambulance transport services to ill, injured or otherwise
incapacitated persons requiring relocation and possible emergency medical care
during flight. Circumstances requiring the Company's transport services include
the relocation of patients requiring specialized medical procedures such as
organ transplants, cancer treatment, specialized cardiac surgery, burn care,
stroke care and advanced brain and spinal cord surgery, as well as
transportation to hospitals and medical facilities recognized nationally for
excellence in their respective fields.

PHYSICAL AND OCCUPATIONAL REHABILITATION provides physical and occupational
speech therapy, and pain rehabilitation services.

PHARMACY SERVICES is a closed network pharmacy located in Lakeland, Florida
which provides unit-dosed medications to over 2,500 residents in assisted living
facilities across Florida. Pharmacy Services delivers medications to the
facilities, and provides training workshops.

TECHNOLOGY ASSISTED DISEASE MANAGEMENT offers the electronic housecall system
and will provide other hardware and software products using Internet technology
for use in disease management services, data gathering, and research.

The accounting policies of the reportable segments are the same as those
described in Note 1 to the Company's Consolidated Financial Statements. The
Company evaluates the performance of its operating segments based upon income
before taxes and nonrecurring and extraordinary items.

Summarized financial information concerning the Company's reportable segments is
shown in the following table. Corporate related items, results of insignificant
operations, and as it relates to segment profit (loss) and income and expense
not allocated to reportable segments are included in the reconciliations to
consolidated results.

F-28
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

Segment information for the years 1999 and 1998 was as follows:

<TABLE>
<CAPTION>
INTERNATIONAL PHYSICAL AND
TECHNOLOGY ASSISTED AIR AMBULANCE OCCUPATIONAL PHARMACY
DISEASE MANAGEMENT TRANSPORT REHAB. SERVICES TOTAL
-------------------- ------------ ------------ ------------ ------------
<S> <C> <C> <C> <C> <C>
1999

Revenue from operations $ 1,567,447 $ 21,055,338 $ 9,311,297 $ 4,710,633 $ 36,644,715
Income (loss) from
continuing
operations ......... (3,862,764) 454,610 791,865 (3,514) (2,619,803)
Depreciation and
amortization .......... 476,880 1,836,735 219,239 74,332 2,607,186
Total assets .......... $ 14,958,873 $ 25,914,641 $ 6,335,724 $ 1,913,386 $ 49,122,824

1998

Revenue from operations $ 1,816,991 $ 7,146,457 $ 1,143,625 $ 2,565,887 $ 12,672,960
Income (loss) from
continuing
operations ......... 218,134 (975,770) (67,359) (14,273) (839,268)
Depreciation and
amortization .......... 130,466 956,687 39,881 50,392 1,177,426
Total assets .......... $ 4,965,012 $ 12,567,707 $ 4,141,226 $ 1,755,507 $ 23,429,452
</TABLE>

Reconciliation to consolidated amounts:

<TABLE>
<CAPTION>
------------ ------------
1999 1998
------------ ------------
<S> <C> <C>
Revenues

Total revenues for reportable segments ....... $ 36,644,715 $ 12,672,960
Other revenues ............................... 1,254,990 758,009
------------ ------------
Revenue from operations .................. $ 37,899,705 $ 13,430,969
============ ============

Income (loss) from continuing operations
Total loss for reportable segments ........... $ (2,619,803) $ (839,268)

Unallocated amounts
Interest -Beneficial conversion feature .. (8,572,247) (1,109,163)
Gain on sale of investment ............... 169,868
Equity in net income (loss) of investee .. -- 80,685
Loss on sale of building ................. -- (234,862)
Merger costs ............................. -- (117,748)
Other .................................... 1,479,559 (1,542,873)
Loss from discontinued operation ......... (1,265,827) (3,617,724)
------------ ------------

Net loss ......................................... $(10,808,451) $ (7,380,953)
============ ============

Assets
Total assets for reportable segments ......... $ 49,122,624 $ 23,429,452
Other assets ................................. 24,603,090 4,784,352
Corporate headquarters - fixed assets ........ 132,801 3,771,156
------------ ------------

Total consolidated assets ........................ $ 73,858,515 $ 27,319,514
============ ============
</TABLE>

F-29
<PAGE>
CYBER-CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 1999

17. SUBSEQUENT EVENTS

In January 2000, the Company entered into an agreement whereby all the Company's
workforce will be leased from an employee leasing company. In exchange for its
leasing services, the employee leasing company charges the company an amount
which covers wages paid to such employees, together with a mark-up assigned to
cover workers' compensation insurance, the provision of a 401(K) plan, payroll
taxes, all other required insurance and a processing and administration fee.

On February 18, 2000, the Company entered into a memorandum of agreement which
calls for the Company and SIIC Medical Science and Technology (Group) Limited
(SIIC) (a Hong Kong public company) to establish a joint venture corporation to
undertake the marketing, application and service rendering of the Company's
"Electronic Housecall System" System and future related technologies and
products within a defined Asian Territory including China. The Company will
initially invest $500,000 for a 33% interest in the joint venture. Subsequent
thereto, the Company signed the Joint venture agreement subject to certain
conditions for the joint venture being set up.

On February 28, 2000, the Company received approximately $11 million, less
underwriter fees, by selling 500,000 shares of the Company's common stock at $22
per share. The Company also issued warrants to purchase up to 100,000 additional
common shares at an exercise price of $31.50 per share.

F-30

EXHIBIT 21.1

LIST OF SUBSIDIARIES

(Each subsidiary is 100% owned unless noted)

o Air Response North, Inc., a Florida corporation

o Carolina Rehab, Inc., a Florida corporation

o CyberCare, Inc., a Georgia corporation

o E-Care Solutions, Inc., a Florida corporation

o Global Air Charter, Inc., a Florida corporation

o Global Air Rescue, Inc., a Delaware corporation

o HELP Innovations Acquisition Corp, Inc., a Florida corporation.

o Pharmacy Care Specialists, Inc., a Florida corporation

o Southeast Medical Centers, Inc., a Florida corporation

o Tallahassee Sleep Disorders, Inc., a Florida corporation

o Your Good Health Network, Inc., a Florida corporation

o Mioa Acquisition Company I, Inc., a Florida corporation

o Mioa Acquisition Company II, Inc., a Florida corporation

o Complete Rehab Services, Inc., a Florida corporation

o Ivanhoe Medical Systems, Inc., a Florida corporation

o Professional Healthcare Services, Inc., a Florida corporation

o Physical Therapy and Rehabilitation, Inc., a Florida corporation

o Professional Rehab Group, Inc., a Florida corporation

o YGHN Acquisition Company I, Inc, a Florida corporation

o Heartlabs of America, Inc. a Florida corporation

o YGHN Acquisition Company II, Inc, a Florida corporation

o Preferred Medical Management Solutions, Inc. a Florida corporation

o Clearwater Jet Center, Inc. a Florida corporation, 51% ownership

<ARTICLE> 5

<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-END> DEC-31-1999
<CASH> 11,758,607
<SECURITIES> 0
<RECEIVABLES> 7,315,607
<ALLOWANCES> 1,465,094
<INVENTORY> 327,380
<CURRENT-ASSETS> 24,266,306
<PP&E> 23,801,666
<DEPRECIATION> 2,927,793
<TOTAL-ASSETS> 73,858,513
<CURRENT-LIABILITIES> 11,440,695
<BONDS> 0
0
0
<COMMON> 121,636
<OTHER-SE> 34,674,436
<TOTAL-LIABILITY-AND-EQUITY> 73,858,515
<SALES> 37,899,705
<TOTAL-REVENUES> 39,155,664
<CGS> 20,981,078
<TOTAL-COSTS> 16,684,311
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 11,032,899
<INCOME-PRETAX> (10,808,451)
<INCOME-TAX> 0
<INCOME-CONTINUING> 9,542,624
<DISCONTINUED> (1,265,827)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (10,808,451)
<EPS-BASIC> (.33)
<EPS-DILUTED> (.33)

</TABLE>